AllianceBernstein National Municipal Income Fund, Inc. Reports Third Quarter Earnings

NEW YORK, Sept. 29 /PRNewswire-FirstCall/ -- AllianceBernstein National Municipal Income Fund, Inc. , a registered closed-end investment company, today announced earnings for the Fund's third fiscal quarter ended July 31, 2009.

Total net assets of the Fund* on July 31, 2009 were $608,352,250, as compared with $598,990,456 on April 30, 2009 and $642,683,156 on July 31, 2008. On July 31, 2009, the net asset value per share of common stock was $12.77 based on 28,662,865 shares of common stock outstanding.

July 31, 2009 April 30, 2009 July 31, 2008 Total Net Assets $608,352,250 $598,990,456 $642,683,156 NAV Per Share $12.77 $12.45 $13.97 Shares Outstanding 28,662,865 28,656,080 28,656,080

For the period May 1, 2009 through July 31, 2009, total net investment income was $7,880,940 or $0.27 per share of common stock. The total net realized and unrealized gain was $8,218,675 or $0.29 per share of common stock for the same period.

Third Quarter Second Quarter Third Quarter Ended Ended Ended July 31, 2009 April 30, 2009 July 31, 2008 Total Net Investment Income $7,880,940 $7,579,616 $7,817,525 Per Share $0.27 $0.26 $0.27 Total Net Realized/ Unrealized Gain/(Loss) $8,218,675 $20,335,348 ($12,015,989) Per Share $0.29 $0.71 ($0.42)

* Total net assets include assets attributable to both common and preferred shares.

AllianceBernstein National Municipal Income Fund, Inc. is managed by AllianceBernstein L.P.

AllianceBernstein National Municipal Income Fund, Inc.

CONTACT: Shareholder Contact, 1-800-221-5672

Alliance California Municipal Income Fund, Inc. Reports Third Quarter Earnings

NEW YORK, Sept. 29 /PRNewswire-FirstCall/ -- Alliance California Municipal Income Fund, Inc. , a registered closed-end investment company, today announced earnings for the Fund's third fiscal quarter ended July 31, 2009.

Total net assets of the Fund* on July 31, 2009 were $184,647,158 as compared with $184,866,062 on April 30, 2009 and $194,789,259 on July 31, 2008. On July 31, 2009, the net asset value per share of common stock was $13.13 based on 8,536,533 shares of common stock outstanding.

July 31, 2009 April 30, 2009 July 31, 2008 Total Net Assets $184,647,158 $184,866,062 $194,789,259 NAV Per Share $13.13 $13.16 $14.32 Shares Outstanding 8,536,533 8,536,533 8,536,533

For the period May 1, 2009 through July 31, 2009, total net investment income was $2,235,236 or $0.26 per share of common stock. The total net realized and unrealized loss was $522,590 or $0.06 per share of common stock for the same period.

Third Quarter Second Quarter Third Quarter Ended Ended Ended July 31, 2009 April 30, 2009 July 31, 2008 Total Net Investment Income $2,235,236 $2,076,481 $2,163,636 Per Share $0.26 $0.24 $0.25 Total Net Realized/ Unrealized Gain/(Loss) ($522,590) $3,821,687 ($2,581,900) Per Share ($0.06) $0.45 ($0.30)

* Total net assets include assets attributable to both common and preferred shares.

Alliance California Municipal Income Fund, Inc. is managed by AllianceBernstein L.P.

Alliance California Municipal Income Fund, Inc.

CONTACT: Shareholder Contact, 1-800-221-5672

Alliance New York Municipal Income Fund, Inc. Reports Third Quarter Earnings

NEW YORK, Sept. 29 /PRNewswire-FirstCall/ -- Alliance New York Municipal Income Fund, Inc. , a registered closed-end investment company, today announced earnings for the Fund's third quarter ended July 31, 2009.

Total net assets of the Fund* on July 31, 2009 were $108,328,287, as compared with $107,179,743 on April 30, 2009 and 110,077,778 on July 31, 2008. On July 31, 2009, the net asset value per share of common stock was $13.99 based on 4,826,667 shares of common stock outstanding.

July 31, 2009 April 30, 2009 July 31, 2008 Total Net Assets $108,328,287 $107,179,743 $110,077,778 NAV Per Share $13.99 $13.75 $14.35 Shares Outstanding 4,826,667 4,826,667 4,826,667

For the period May 1, 2009 through July 31, 2009, total net investment income was $1,231,829 or, $0.26 per share of common stock. The total net realized and unrealized gain was $921,653 or $0.19 per share of common stock for the same period.

Third Quarter Second Quarter Third Quarter Ended Ended Ended July 31, 2009 April 30, 2009 July 31, 2008 Total Net Investment Income $1,231,829 $1,148,986 $1,197,597 Per Share $0.26 $0.24 $0.25 Total Net Realized/ Unrealized Gain/(Loss) $921,653 $1,986,094 ($1,146,482) Per Share $0.19 $0.41 ($0.24)

* Total net assets include assets attributable to both common and preferred shares.

Alliance New York Municipal Income Fund, Inc. is managed by AllianceBernstein L.P.

Alliance New York Municipal Income Fund, Inc.

CONTACT: Shareholder Contact, 1-800-221-5672

AllianceBernstein National Municipal Income Fund, Inc. Monthly Distribution

NEW YORK, Sept. 29 /PRNewswire-FirstCall/ -- AllianceBernstein National Municipal Income Fund, Inc. , a closed-end management investment company, declared on this date, September 29, 2009, a monthly distribution of $0.0755 per share of Common Stock, payable October 23, 2009 to shareholders of record at the close of business on October 9, 2009. Exdate will be October 7, 2009.

AllianceBernstein National Municipal Income Fund, Inc. is managed by AllianceBernstein L.P.

AllianceBernstein National Municipal Income Fund, Inc.

CONTACT: Shareholder Contact: +1-800-221-5672

Alliance California Municipal Income Fund, Inc. Monthly Distribution

NEW YORK, Sept. 29 /PRNewswire-FirstCall/ -- Alliance California Municipal Income Fund, Inc. , a closed-end management investment company, declared on this date, September 29, 2009, a monthly distribution of $0.0715 per share of Common Stock, payable October 23, 2009 to shareholders of record at the close of business on October 9, 2009. Exdate will be October 7, 2009.

Alliance California Municipal Income Fund, Inc. is managed by AllianceBernstein L.P.

Alliance California Municipal Income Fund, Inc.

CONTACT: Shareholder Contact: 1-800-221-5672

AllianceBernstein Global High Income Fund, Inc. Monthly Distribution

NEW YORK, Sept. 29 /PRNewswire-FirstCall/ -- AllianceBernstein Global High Income Fund, Inc. , a closedend management investment company, declared on this date, September 29, 2009, a monthly distribution of $0.0925 per share of Common Stock, payable October 23, 2009 to shareholders of record at the close of business on October 9, 2009. Exdate will be October 7, 2009.

AllianceBernstein Global High Income Fund, Inc. is managed by AllianceBernstein L.P.

AllianceBernstein Global High Income Fund, Inc.

CONTACT: Shareholder Contact, +1-800-221-5672

AllianceBernstein Income Fund, Inc. Monthly Distribution

NEW YORK, Sept. 29 /PRNewswire-FirstCall/ -- AllianceBernstein Income Fund, Inc. , a closed-end management investment company, declared on this date, September 29, 2009, a monthly distribution of $0.050 per share of Common Stock, payable October 23, 2009 to shareholders of record at the close of business on October 9, 2009. Exdate will be October 7, 2009.

AllianceBernstein Income Fund, Inc. is managed by AllianceBernstein L.P.

AllianceBernstein Income Fund, Inc.

CONTACT: Shareholder Contact, 1-800-221-5672

Alliance New York Municipal Income Fund, Inc. Monthly Distribution

NEW YORK, Sept. 29 /PRNewswire-FirstCall/ -- Alliance New York Municipal Income Fund, Inc. , a closed-end management investment company, declared on this date, September 29, 2009, a monthly distribution of $0.0655 per share of Common Stock, payable October 23, 2009 to shareholders of record at the close of business on October 9, 2009. Exdate will be October 7, 2009.

Alliance New York Municipal Income Fund, Inc. is managed by AllianceBernstein L.P.

Alliance New York Municipal Income Fund, Inc.

CONTACT: Shareholder Contact, +1-800-221-5672

Gryphon Resources Begins Oil & Gas Acquisition Negotiation and Reports Manganese Analysis

IZMIR, Turkey, Sept. 29 /PRNewswire-FirstCall/ -- Gryphon Resources reported today it has begun negotiations for purchase of a significant oil & gas exploration interest in Turkey. CEO Serdar Kirmizioglu described this initiative "As a significant expansion of our strategic plans which effectively diversifies the Company. This is a good opportunity and we're confident we can successfully manage oil exploration and continued exploration for manganese and copper. Negotiations are expected to conclude within the next several weeks and we see this as a positive development for our future marketability."

Gryphon Resources also reported findings of an independent geologist who visited Gryphon's H33D4 manganese exploration site in Turkey. An examination of H33D4 done by Dr. Warren Pratt showed a block of manganese mineralization measuring approximately 20 x 15 x 5 metres with a grade of approximately 45%, plus other lower grade manganese mineralization. The visible high grade manganese deposit occurs within a complex mega-breccia (melange) deposit. Other similar manganese blocks are not visible at the surface and no drilling has yet been undertaken. Based on his findings, Dr. Pratt cannot verify previous analysis of the Company that H33D4 supports the existence of an extensive high grade manganese deposit. However, there is evidence of low grade manganese mineralization hosted by a tectonised sequence of ophiolitic rocks. This mineralization extends for at least 400 metres along strike and is composed of a manganiferous chert approximately 3 metres thick on average. This mineralization is estimated to have a grade of approximately 1.2 - 5.7% and does not present an economical case for exploitation at this time. The Company intends to expand its exploration efforts for manganese and copper on the H33D4 site.

About Gryphon Resources

Gryphon Resources Inc. trades on the OTC-BB under the symbol GRYO. The Company was incorporated in Nevada in 2006 and incorporated its subsidiary APM Madencilik Ltd. in Turkey in 2008. Gryphon has undertaken exploration initiatives in Canada and Turkey and is focused on manganese, copper and oil exploration.

CAUTIONARY STATEMENT ON FORWARD-LOOKING INFORMATION

Certain information contained in this press release, including any information as to our strategy, plans or future financial or operating performance and other statements that express management's expectations or estimates of future performance, constitute "forward-looking statements." All statements, other than statements of historical fact, are forward-looking statements. The words "believe," "expect," "will," "anticipate," "contemplate," "target," "plan," "continue," "budget," "may," "intend," "estimate," "project" and similar expressions identify forward-looking statements. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond the company's control with respect to mining operations, changes in the worldwide price of manganese, copper or certain other commodities; legislative, political or economic developments in the jurisdictions in which the Company carries on business; operating or technical difficulties in connection with mining or development activities; employee relations; contests over title to properties; and the risks involved in the exploration, development and mining business. The Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

Gryphon Resources Inc.

CONTACT: Serdar Kirmizioglu of Gryphon Resources Inc., +1-360-685-4238

Web Site: http://www.gryphonresourcesinc.com/

Hyperdynamics to Hold Business Update Investor Conference Call September 30 at 10 a.m. CT

SUGAR LAND, Texas, Sept. 29 /PRNewswire-FirstCall/ -- Hyperdynamics Corporation (NYSE Amex: HDY) will host an investor conference call on Wednesday, September 30, at 10 a.m. Central Time to provide an overall business update and to discuss details of a new Memorandum of Understanding with the government of the Republic of Guinea signed earlier this month.

Investors may participate in the call either by phone or audio webcast. By Phone: Dial 719-457-2713 at least 10 minutes before the call. By Webcast: Visit the Events and Presentations page of Hyperdymnamics' Investor Relations website at http://investors.hyperdynamics.com/events.cfm. Please log on at least 10 minutes early to register and download any necessary audio software. A replay of the audio webcast will be available shortly after the call. About Hyperdynamics

Hyperdynamics is committed to providing energy for the future by exploring internationally for new sources of oil and gas. It holds the largest exploration and production license in West Africa in the Republic of Guinea covering 31,000 square miles. To find out more, visit the corporate website at http://www.hyperdynamics.com/.

HDY-IR

Hyperdynamics Corporation

CONTACT: Ken Dennard, Managing Partner, or Jack Lascar, Partner,
+1-713-529-6600, or Anne Pearson, Sr. Vice President, +1-210-408-6321, all of
Dennard Rupp Gray & Easterly, LLC, for Hyperdynamics Corporation

Web Site: http://www.hyperdynamics.com/

Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)

SAN DIEGO, Sept. 29 /PRNewswire-FirstCall/ -- Orexigen® Therapeutics, Inc. , a biopharmaceutical company focused on the treatment of obesity, plans to announce the results of a Phase 2b trial for Empatic(TM) on Wednesday, September 30, 2009 before the markets open. The announcement will be followed by a live webcast and conference call at 8:30 a.m. Eastern time.

Orexigen management will host the call and webcast to discuss the results of this clinical trial and answer questions. The live call may be accessed by phone by calling (800).884.5695 (domestic) or (617).786.2960 (international), participant code 64389662. The webcast can be accessed live on the investor relations section of the Orexigen web site at http://www.orexigen.com/, and will be archived for 14 days following the call.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead investigational product, Contrave, has completed Phase 3 clinical trials and is on track for a regulatory submission with the FDA in the first half of 2010. The Company's second product candidate, Empatic, has completed Phase 2 clinical development. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss, through combination therapeutic approaches. Further information about the Company can be found at http://www.orexigen.com/.

Orexigen Therapeutics, Inc.

CONTACT: Graham Cooper of Orexigen Therapeutics, Inc., +1-858-875-8600;
or Media, Liz Frank, +1-212-301-7216, or Lori Rosen, +1-212-301-7173, both for
Orexigen Therapeutics, Inc.

Web Site: http://www.orexigen.com/

LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results

SAN DIEGO, Sept. 29 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), a science-based, natural products company dedicated to helping people reach their health and wellness goals through science-based solutions for oxidative stress and the maker of both Protandim® and TrueScience(TM) Anti-Aging Cream, announced today fourth quarter and fiscal year 2009 financial and operating results.

The Company recorded net revenues of $4.1 million and a net loss of ($9.1) million, or ($0.23) per share, for its year ended June 30, 2009. For its year ended June 30, 2008, the Company recorded net revenues of $3.2 million and a net loss of ($2.1) million or ($0.09) per share.

During its fourth quarter fiscal year 2009, the Company recorded net revenue of $1.6 million, which represents an increase of approximately 150% from the net revenue of $0.6 million for the third quarter fiscal year 2009 and a net loss of ($5.3) million or ($0.11) per share. During its fourth quarter fiscal year 2008, the Company recorded net revenues of $0.8 million and a net loss of $(0.7) million, or $(0.03) per share.

"This past fiscal year has been a transitional one for LifeVantage," stated David W. Brown, President & CEO. "We entered the multi-billion dollar network marketing industry, by far the fastest growing sales channel for dietary supplements, and we believe, the best avenue for marketing the Company's products. Furthermore, we announced a unique 'inside-out' approach to anti-aging with the launch of our second product, TrueScience Anti-Aging Cream. On the inside of the body, Protandim, our flagship nutritional supplement, has been clinically proven to reduce the rate of cellular aging. Offering a unique, effective skin care product to address the skin, or the 'outside,' was a logical extension of our Protandim product line. Continuing with our expansion, we entered the international market with a pre-launch in Mexico, which ranks among the top five countries in terms of network marketing, with a full launch anticipated later this year."

"The increase in yearly as well as fourth quarter revenue is directly attributable to our launch into network marketing as well as the addition of a team of some of the most sought after and highest producing independent distributors in the network marketing industry," added Brown. "Furthermore, we believe our executive team members, CFO Carrie Carlander and COO Kirby Zenger, have proven to be tremendous assets to the Company. Carrie has an impressive background and track record with dynamic public companies with proven abilities in corporate governance, strategic planning, investor relations, and finance. Kirby brings varied and invaluable experience from the network marketing industry as well as traditional business and has a proven track record in building and growing network marketing sales organizations at an impressive rate. We believe the team we now have in place can best continue to move the Company forward and significantly impact the growth of our network marketing distribution model."

Carrie Carlander, CFO, added: "Earlier this year, LifeVantage launched into the network marketing sales channel and we look forward to continuing to realize the benefits of our new team and revenue model. Most of the expenses related to the addition of the new team, marketing expenses necessary to re-launch the Company and our second product, TrueScience Anti-Aging Cream, as well as litigation expenses have now been recognized. We have also implemented reductions in overhead and operating expenses and moving forward we are poised to execute our growth plans with a more efficient corporate and operational structure."

Key Corporate Developments Third Patent for Protandim Issued

In September 2009, the Company announced that it had been granted a third patent for Protandim, "Methods for Enhancing Antioxidant Enzyme Activity and Reducing C-Reactive Protein Levels," which was issued on August 25, 2009. This patent claims the use of Protandim for increasing antioxidant enzyme activity and further documents Protandim's effect on antioxidant enzymes in vivo, describing anti-inflammatory effects such as the lowering of C-reactive protein. C-reactive protein is widely considered by doctors and researchers as an indicator of the amount of inflammation present in the body. Elevated basal levels of C-reactive protein are considered risk factors for diabetes, hypertension, and cardiovascular disease.

Mexico Pre-Launch Announced

In August 2009, the Company announced that it was entering the international market with a pre-launch in Mexico, one of the top network marketing countries in the world, with independent distributor applications and orders being accepted in anticipation of a launch later this year. Network marketing companies have traditionally achieved outstanding results in Mexico and that, coupled with the fact that LifeVantage has strong distributor relationships in the country, were key factors in the expansion decision. As well, nutrition and wellness product sales are booming in Mexico and the Company believes that Protandim and TrueScience are ideal for this market, especially with the research and science that supports the Company's products.

TrueScience Anti-Aging Cream Launched

In June 2009, the Company launched its LifeVantage TrueScience Anti-Aging Cream, a scientifically-based, groundbreaking and unique skin care product which includes natural and effective ingredients, including those found in Protandim. This new, proprietary skin care formula was developed in association with Kimberly Stone, M.D., a Denver-based board certified dermatologist, and is formulated to protect the skin from a variety of factors that contribute to aging and the symptoms of unhealthy skin.

Peer-Reviewed Publications Surrounding Protandim

During fiscal year 2009, several peer-reviewed preclinical studies involving our flagship product Protandim, were published.

In April 2009, the findings from a Louisiana State University peer-reviewed study were published in the journal PLoS ONE, an international, peer-reviewed, open-access journal published by the Public Library of Science. The abstract was entitled "Protandim, a Fundamentally New Antioxidant Approach in Chemoprevention Using Mouse Two-Stage Skin Carcinogenesis as a Model". A two-stage mouse skin carcinogenesis study was performed to investigate whether Protandim could suppress tumor formation by a dietary approach. The preclinical study concluded that overall, induction of antioxidant enzymes by Protandim may serve as a practical and potent approach for cancer prevention.

In February 2009, the results of a preclinical study were published in the journal Free Radical Biology and Medicine. The study was conducted by scientists at the University of Colorado Denver and Ochsner Medical Center and demonstrated that all five of Protandim's active ingredients contribute synergistically to the composition's activity, allowing it to work at low, pharmacologically attainable doses of each. Even low doses of Protandim were shown to induce human cells to increase their production of many antioxidant enzymes, and other anti-aging factors.

Furthermore, this study demonstrated that the synergistic impact of the active ingredients used in the formulation of Protandim increases the cell's production of glutathione, a key antioxidant and anti-aging factor, by more than 300 percent, as well as increases the important antioxidant enzyme heme oxygenase-1. Glutathione plays a key role in the immune system and when glutathione levels drop, a person's ability to fight disease decreases. The study also demonstrated that Protandim delivered antioxidant benefits to cells in ways that are not affected at all by conventional direct antioxidants such as vitamins E and C.

Protandim is currently the subject of approximately 20 independent scientific studies at various universities and research facilities. The nature and stages of the studies vary, as some are still in planning stages, while other studies are currently in progress. Universities and institutions conducting research include the University of Colorado; Colorado State University; Denver Health Medical Center; Children's Hospital, Denver; the University of Florida; the University of Kentucky; the University of Michigan; Louisiana State University; Ohio State University; Vanderbilt University; Glamorgan University, Wales; Sahlgrenska University Hospital, Sweden; Harvard University; and the Mexican Institute of Social Security, Mexico City. The various studies deal with the alleviation of oxidative stress under the following conditions: altitude sickness, non-alcoholic steatohepatitis, lung antioxidant status in withdrawing alcoholics, autonomic physiology and aging, skin cancer, photoaging of the skin, osteoarthritis, HIV/AIDS-associated lipodystrophy, pulmonary hypertension, periodontal disease, heart disease, coronary artery bypass graft failure, asthma, Duchenne muscular dystrophy, metabolic syndrome, and optic neuropathy.

About LifeVantage Corporation

LifeVantage Corporation is a publicly traded (OTCBB: LFVN), science-based, nutraceutical company dedicated to helping people reach their health and wellness goals. Founded in 2003 and based in San Diego, CA, LifeVantage develops products, including Protandim®, that deliver significant health benefits to consumers. For more information, visit http://www.lifevantage.com/.

About Protandim®

Protandim® is a clinically proven supplement that provides substantial benefits for healthy aging. This patented indirect antioxidant therapy works in a very different way than conventional foods such as red wine, oranges, blueberries or other popular antioxidant supplements. Unlike those types of products that have proven to be largely ineffective in reducing oxidative stress caused by free radicals, Protandim® is an indirect antioxidant therapy, which stimulates the body's production of its own powerful antioxidant enzymes. Protandim® works at the cellular level, triggering cells to naturally increase production of protective antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione synthase.

A peer-reviewed human clinical study showed that after Protandim® was taken for 30 consecutive days, important biochemical markers of aging were decreased by an average of 40%. The study also reported that these markers of aging were reduced in the subjects taking Protandim® to the level of a typical 20 year old. Protandim® is currently the subject of approximately 20 scientific studies at various universities and research facilities. The nature and stages of the studies vary, as some of the testing is at a preliminary stage, while other studies using Protandim® are currently in progress. For more information about Protandim®, visit http://www.lifevantage.com/.

About LifeVantage TrueScience(TM) Anti-Aging Cream

LifeVantage TrueScience(TM) is scientifically-based and contains cutting-edge ingredients, including those found in Protandim®. LifeVantage TrueScience(TM) Anti-Aging Cream gives skin a beautiful, even and smooth tone, diminishes the appearance of fine lines and wrinkles, and provides a vibrant and glowing appearance. LifeVantage TrueScience(TM) also improves skin smoothness and pigmentation, while increasing skin moisture. For more information about LifeVantage TrueScience(TM), visit http://www.lifevantage.com/.

Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates" and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, the potential failure or unintended negative consequences of the implementation of our network marketing sales channel; our ability to retain independent distributors or to attract new independent distributors on an ongoing basis; the potential for third party and governmental actions involving our network marketing sales channel; the potential for product liability claims against the Company; the risk that government regulators and regulations could adversely affect our business; future laws or regulations may hinder or prohibit the production or sale of our existing product and any future products; unfavorable publicity could materially hurt our business; and the Company's ability to protect our intellectual property rights and the value of our product. These and other risk factors are discussed in greater detail in the Company's Annual Report on Form 10-K and Quarterly Report on Form 10-Q under the caption "Risk Factors", and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Investor Contact: Ioana C. Hone (858) 312-8000 Ext. 4 Media Contact: For LifeVantage Corporation Jan Strode, 619-890-4040 Jean Golden, 612-385-2324 LIFEVANTAGE CORPORATION AND SUBSIDIARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS For the years ended ------------------- June 30, 2009 June 30, 2008 ------------- ------------- Sales, net $4,141,304 $3,200,174 Cost of sales 852,804 695,386 ------- ------- Gross profit 3,288,500 2,504,788 Operating expenses: Sales and marketing 4,107,768 1,655,461 General and administrative 6,588,414 2,108,338 Research and development 224,366 324,106 Depreciation and amortization 173,030 219,690 ------- ------- Total operating expenses 11,093,578 4,307,595 ---------- --------- Operating (loss) (7,805,078) (1,802,807) Other income and (expense): Interest income 20,474 45,315 Interest (expense) (1,330,030) (296,947) ---------- -------- Total other (expense) income (1,309,556) (251,632) ---------- -------- Net (loss) $(9,114,634) $(2,054,439) =========== =========== Net (loss) per share, basic and diluted $(0.23) $(0.09) ====== ====== Weighted average shares outstanding, basic and diluted 40,360,592 22,710,096 ========== ========== The Notes included in the Form 10-K for the year ended June 30, 2009 are an integral part of these financial statements. LIFEVANTAGE CORPORATION AND SUBSIDIARY CONDENSED CONSOLIDATED BALANCE SHEETS June 30, 2009 June 30, 2008 ------------- ------------- ASSETS ------ Current assets Cash and cash equivalents $608,795 $196,883 Restricted Cash 259,937 - Marketable securities, available for sale 520,000 1,100,000 Accounts receivable, net 648,116 98,008 Equity raise receivable 119,750 - Inventory 740,014 104,415 Deferred expenses 10,000 72,049 Deposit with manufacturer 6,482 277,979 Prepaid expenses 72,738 124,049 ------ ------- Total current assets 2,985,832 1,973,383 Long-term assets Marketable securities, available for sale 130,000 - Property and equipment, net 274,741 63,559 Intangible assets, net 2,175,281 2,270,163 Deferred debt offering costs, net 83,023 193,484 Deposits 66,795 48,447 ------ ------ TOTAL ASSETS $5,715,672 $4,549,036 ========== ========== LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY ---------------------------------------------- Current liabilities Accounts payable $2,029,290 $139,803 Accrued expenses 822,024 338,268 Deferred revenue - 510,765 Escrow for equity offering 259,937 - Revolving line of credit and accrued interest 581,444 166,620 Capital lease obligations, current Portion 41,490 846 ------ --- Total current liabilities 3,734,185 1,156,302 Long-term liabilities Deferred rent 23,677 - Derivative warrant liability 8,429,710 - Convertible debt, net of discount 382,194 223,484 ------- ------- Total liabilities 12,569,766 1,379,786 ---------- --------- Commitments and contingencies Stockholders' (deficit) equity Preferred stock - par value $.001, 50,000,000 shares authorized, no shares issued or outstanding - - Common stock, - par value $.001, 250,000,000 shares authorized and 53,968,628 and 24,766,117 issued and outstanding as of June 30, 2009 and 2008, respectively 53,969 24,766 Additional paid-in capital 16,964,927 17,902,840 Accumulated (deficit) (23,872,990) (14,758,356) ----------- ----------- Total stockholders' (deficit) equity (6,854,094) 3,169,250 ---------- --------- TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY $5,715,672 $4,549,036 ========== ========== The Notes included in the Form 10-K for the year ended June 30, 2009 are an integral part of these financial statements.

LifeVantage Corporation

CONTACT: Investors, Ioana C. Hone of LifeVantage Corporation,
+1-858-312-8000 Ext. 4; or Media, Jan Strode, +1-619-890-4040, or Jean Golden,
+1-612-385-2324, both for LifeVantage Corporation

Web Site: http://www.lifevantage.com/

Caraco Pharmaceutical Laboratories, Ltd. Enters Into Consent Decree with FDA Providing Path to Resume Manufacturing Operations

DETROIT, Sept. 29 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced today that it has entered into a consent decree with the U.S. Food and Drug Administration (FDA) regarding the company's drug manufacturing operations. The decree provides a series of measures that, when satisfied, will permit Caraco to resume manufacturing and distributing those products that are manufactured in its Detroit area facilities. The Company is working expeditiously to satisfy the requirements of the decree and has already retained independent cGMP experts for review of the Company's operations and to facilitate a successful result.

Under terms of the consent decree, Caraco's cessation of manufacturing operations will continue until it receives written notification from independent experts and the FDA that it is in compliance with the decree and regulations and can resume operations. Nothing in the decree prohibits Caraco from distributing FDA approved drug products that are manufactured by third parties.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Without limitation, the words "believe" or "expect" and similar expressions are intended to identify forward-looking statements. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission, including Part I, Item 1A of our most recent Form 10-K, and include but are not limited to: information of a preliminary nature that may be subject to adjustment, potentially not obtaining or delay in obtaining FDA approval for new products, governmental restrictions on the sale of certain products, development by competitors of new or superior products or less expensive products or new technology for the production of products, the entry into the market of new competitors, market and customer acceptance and demand for new pharmaceutical products, availability of raw materials, timing and success of product development and launches, dependence on few products generating majority of sales, product liability claims for which the Company may be inadequately insured, material litigation from product recalls, the purported class action lawsuits alleging federal securities laws violations, delays in returning the Company's products to market, including loss of market share, increased reserves against the FDA-seized inventory, and other risks identified in this report and from time to time in our periodic reports and registration statements. These forward-looking statements represent our judgment as of the date of this report. We disclaim, however, any intent or obligation to update our forward-looking statements.

Caraco Pharmaceutical Laboratories, Ltd.

CONTACT: Jitendra Doshi, +1-313-871-8400, or Thomas Versosky,
+1-313-556-4150, both of Caraco Pharmaceutical

Sealy Corporation Reports Third Quarter Fiscal 2009 Results-Income from Operations Grows 21.6%- -Adjusted EBITDA Grows 14.7%- -Operating & Adjusted EBITDA Margin Expansion-

TRINITY, N.C., Sept. 29 /PRNewswire-FirstCall/ -- Sealy Corporation , the bedding industry's largest global manufacturer, today announced results for its third quarter of fiscal 2009.

Income from operations for the third fiscal quarter increased $7.0 million to $39.2 million compared to the same period in the prior year. As a percent of sales, income from operations increased 325 basis points to 11.2% from the same prior year period.

Adjusted EBITDA for the third fiscal quarter increased to $53.7 million from $46.8 million, while Adjusted EBITDA margin increased 380 basis points to 15.4% compared to the same prior year period.

Net sales for the third fiscal quarter were $349.6 million compared to $405.0 million in the same prior year period.

Gross Profit for the third fiscal quarter was $146.1 million compared to $164.1 in the same prior year period, while Gross Margin increased 126 basis points over the same time period, to 41.8%.

Net income for the third fiscal quarter was $12.1 million versus net income of $10.9 million for the comparable prior year period. Third quarter 2009 earnings per diluted share, based on a 279.2 million diluted share count, was $0.05, compared to earnings per diluted share, based on a 93.5 million diluted share count, of $0.12 in the prior year. A reconciliation for the increase in shares outstanding can be found in the attached schedules.

"We were pleased with the results from the continued execution of our 2009 strategic initiatives to grow profitable market share; successfully roll out the new Stearns & Foster line; build stronger partnerships with our retailers and suppliers; improve our gross margins; permanently reduce our operating cost structure; and maximize our financial flexibility. These actions have all contributed to the year-over-year and sequentially improving results that we are reporting today," stated Larry Rogers, Sealy's President and Chief Executive Officer.

"While the global macro economic and retail environments remain challenging, we believe our focus on the aspects of our business that we can control is paying off. One prominent example of this is the success that we are seeing in the luxury bedding market with our new Stearns & Foster line. Efforts like this are enabling us to begin to realize improvements in our operations and positioning us to benefit more when the economy improves," added Mr. Rogers.

Total U.S. net sales were $256.8 million, a decrease of 13.3% from the third quarter of fiscal 2008. Wholesale domestic net sales, which exclude third party sales from Sealy's component plants, were $251.8 million, compared to $289.0 million in the third quarter of 2008. A weak retail environment negatively impacted domestic revenue performance. In the U.S., Wholesale Average Unit Selling Price (AUSP) increased 0.1% while unit volume declined 12.9% on a year-over-year basis.

International net sales decreased $16.0 million, or 14.7%, from the third quarter of 2008 to $92.8 million. Excluding the effects of currency fluctuation, International net sales declined 4.3% from the third quarter of 2008. This decline was primarily due to declines in finished goods sales in Europe and, to a lesser extent, the weak retail environment in our Latin American businesses.

Consolidated gross profit was $146.1 million compared to $164.1 million in the third quarter of fiscal 2008. Gross profit margin was 41.8%, an increase of 126 basis points compared to the prior year third quarter. U.S. gross profit margin increased 109 basis points to 43.9%. The increase in gross profit margin was driven primarily by lower material costs as the related commodity prices remained below prior year levels through the third quarter and continued improvements in manufacturing efficiencies, which were partially offset by less absorption of fixed costs as a result of lower volume.

Selling, general, and administrative (SG&A) expenses were $110.3 million for the third quarter of fiscal 2009, an improvement of $22.6 million, versus the comparable period a year earlier. The reduction in SG&A expenses is primarily due to actions taken by management to reduce the Company's cost structure. Volume driven variable expenses declined $14.9 million. Fixed operating costs, exclusive of compensation expense, decreased $17.0 million primarily due to a $10.1 million reduction in national advertising expenses as well as reductions in other operating expenditures. Compensation expense increased by $9.3 million primarily due to increases for incentive-based payments, defined contribution plan payments, and non-cash compensation expense related to new equity grants.

Income from operations for the third fiscal quarter increased $7.0 million to $39.2 million compared to the same period in the prior year. As a percent of sales, income from operations increased 325 basis points to 11.2% from the same prior year period. This improvement was based on improved gross profit margin performance and continued cost improvements.

Total Adjusted EBITDA was $53.7 million for the third quarter of fiscal 2009, or 15.4% of net sales, which represents an increase of 380 basis points on a year-over-year basis.

For the nine months ended August 30, 2009, Net Sales decreased 18.3% to $958.0 million from $1,172.3 million for the comparable prior year period. Gross profit was $386.5 million, or 40.3% of net sales, versus $465.7 million, or 39.7% of net sales, for the comparable prior year period a year earlier. Income from operations was $92.2 million or 9.6% of net sales compared to $108.0 million or 9.2% of net sales for the comparable prior year period. Net income was $11.6 million versus $39.1 million and net income per diluted share was $0.09 compared to $0.42 for the comparable prior year period. Results for the period included charges of $16.2 million net of tax or $0.11 per diluted share, related to the Company's refinancing of its senior credit facility on May 29, 2009 and rights for convertible notes. Total Adjusted EBITDA was $130.8 million, or 13.7% of net sales, versus $147.8 million, or 12.6% of net sales, compared for the nine months ended August 31, 2008.

As of August 30, 2009, the Company's debt net of cash was $749.6 million, a decrease of $7.2 million compared to $756.8 million as of November 30, 2008 and a decrease of $11.3 million compared to the Company's debt net of cash of $760.9 million as of May 31, 2009. The Net Debt to EBITDA ratio excluding the convertible notes was 3.76x as compared to 4.03x as of May 31, 2009.

"The completion of our comprehensive refinancing plan in July, coupled with our strong cash flow generation and our negotiated ability to pre-pay a portion of this debt, has created a stable long-term financial position with greater financial flexibility for the Company. The Company has no material amortization payments until 2014," stated Mr. Rogers.

"While we expect market conditions to remain challenging, we are starting to see positive signs in the market in terms of volume and pricing, although not with sufficient consistency to definitively conclude we are in a turnaround. We continue to remain vigilant on right sizing our cost structure and rebuilding gross margins in order to maximize our cash flow.

"We believe that our recent operating performance and successful financial restructuring leave our company in a stronger strategic position to gain profitable market share and drive increasing value for our shareholders," concluded Mr. Rogers.

Adjusted EBITDA

Within the information above, Sealy provides information regarding Adjusted EBITDA and Adjusted EBITDA Margin which are not recognized terms under GAAP (Generally Accepted Accounting Principles) and do not purport to be alternatives to operating income or net income as a measure of operating performance or to cash flows from operating activities as a measure of liquidity. We present Adjusted EBITDA and its derivative, Adjusted EBITDA Margin, because the covenants contained in our senior debt agreements are based upon these measures and Adjusted EBITDA is a material component of those covenants. Additionally, these measures are not intended to be measures of available cash flow for management's discretionary use, as these measures do not consider certain cash requirements such as interest payments, tax payments and debt service requirements. Because not all companies use identical calculations, this presentation may not be comparable to other similarly titled measures of other companies. A reconciliation of Adjusted EBITDA and Adjusted EBITDA Margin to the Company's income from operations is provided in the attached schedule.

Conference Call

The Company will hold a conference call today to discuss its fiscal third quarter 2009 results at 5:00 p.m. (Eastern Time). The conference call can be accessed live over the phone by dialing 1-877-941-2068, or for international callers, 1-480-629-9712. A replay will be available one hour after the call and can be accessed by dialing 1-800-406-7325, or for international callers, 1-303-590-3030. The passcode for the live call and the replay is 4157344. The replay will be available until October 6, 2009.

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investors section of the Company's website at http://www.sealy.com/. The on-line replay will be available for a limited time beginning immediately following the call. An updated investor presentation will be posted on Wednesday, September 30th, in the Investors section of the Company's website at http://www.sealy.com/.

About Sealy

Sealy is the bedding industry's largest global manufacturer with sales of $1.5 billion in fiscal 2008. The Company manufactures and markets a broad range of mattresses and foundations under the Sealy(R), Sealy Posturepedic(R), including SpringFree(TM), PurEmbrace(TM) and TrueForm(R); Stearns & Foster(R), and Bassett(R) brands. Sealy operates 25 plants in North America, and has the largest market share and highest consumer awareness of any bedding brand on the continent. In the United States, Sealy sells its products to approximately 3,000 customers with more than 7,000 retail outlets. Sealy is also a leading supplier to the hospitality industry. For more information, please visit http://www.sealy.com/.

This document contains forward-looking statements within the meaning of the safe harbor provisions of the Securities Litigation Reform Act of 1995. Terms such as "expect," "believe," "continue," and "grow," as well as similar comments, are forward-looking in nature. Although the Company believes its growth plans are based upon reasonable assumptions, it can give no assurances that such expectations can be attained. Factors that could cause actual results to differ materially from the Company's expectations include: general business and economic conditions, competitive factors, raw materials purchasing, and fluctuations in demand. Please refer to the Company's Securities and Exchange Commission filings for further information.

SEALY CORPORATION CONDENSED CONSOLIDATED BALANCE SHEET (In thousands) (Unaudited) August 30, November 30, August 31, 2009 2008 2008 ---- ---- ---- ASSETS Current assets: Cash and equivalents $99,840 $26,596 $30,699 Accounts receivable, net of allowances for bad debts, cash discounts and returns 189,446 156,583 225,115 Inventories 57,619 64,634 73,059 Prepaid expenses and other current assets 23,726 30,969 26,977 Deferred income tax assets 18,724 16,775 17,057 ------ ------ ------ Total current assets 389,355 295,557 372,907 ------- ------- ------- Property, plant and equipment - at cost 440,003 449,308 462,890 Less accumulated depreciation (220,656) (218,560) (219,754) -------- -------- -------- 219,347 230,748 243,136 ------- ------- ------- Other assets: Goodwill 360,817 357,149 393,507 Intangible assets, net of accumulated amortization 2,774 4,945 6,277 Deferred income tax assets 5,650 3,392 3,909 Debt issuance costs, net, and other assets 53,740 29,083 31,400 ------ ------ ------ 422,981 394,569 435,093 Total assets $1,031,683 $920,874 $1,051,136 ========== ======== ========== LIABILITIES AND STOCKHOLDERS' DEFICIT Current liabilities: Current portion - long-term obligations $11,591 $21,243 $37,937 Accounts payable 105,914 97,084 160,654 Accrued incentives and advertising 31,610 34,542 39,861 Accrued compensation 33,730 24,797 26,160 Accrued interest 14,843 16,432 10,765 Other accrued liabilities 45,178 44,363 48,124 ------ ------ ------ Total current liabilities 242,866 238,461 323,501 Long-term obligations, net of current portion 837,836 762,162 741,680 Other liabilities 59,585 71,257 67,955 Deferred income tax liabilities 6,538 4,962 6,990 Common stock and options subject to redemption - 8,856 9,424 Stockholders' deficit: Common stock 922 917 916 Additional paid-in capital 878,003 668,547 667,480 Accumulated deficit (991,572) (814,298) (772,318) Accumulated other comprehensive income (2,495) (19,990) 5,508 Total shareholders' deficit (115,142) (164,824) (98,414) Total liabilities and shareholders' deficit $1,031,683 $920,874 $1,051,136 ========== ======== ========== SEALY CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) (Unaudited) Three Months Ended ------------------ August 30, August 31, 2009 2008 ---- ---- Net sales $349,573 $404,963 Cost of goods sold 203,508 240,843 ------- ------- Gross profit 146,065 164,120 Selling, general and administrative expenses 110,256 132,892 Amortization expense 842 981 Restructuring expenses and asset impairment - 2,448 Royalty income, net of royalty expense (4,216) (4,422) ------ ------ Income from operations 39,183 32,221 Interest expense 22,127 14,379 Loss on rights for convertible notes 1,820 - Refinancing and extinguishment of debt and interest rate derivatives 39 - Other income, net (14) (117) --- ---- Income before income tax provision 15,211 17,959 Income tax provision 3,155 7,017 ----- ----- Net income $12,056 $10,942 ======= ======= Earnings per common share--- Basic $0.13 $0.12 ===== ===== Earnings per common share--- Diluted $0.05 $0.12 ===== ===== Weighted average number of common shares outstanding: Basic 91,884 91,269 Diluted 279,156 93,538 SEALY CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) (Unaudited) Nine Months Ended ----------------- August 30, August 31, 2009 2008 ---- ---- Net sales $958,004 $1,172,267 Cost of goods sold 571,538 706,579 ------- ------- Gross profit 386,466 465,688 Selling, general and administrative expenses 302,533 365,536 Amortization expense 2,435 2,850 Restructuring expenses and asset impairment 1,448 2,907 Royalty income, net of royalty expense (12,186) (13,558) ------- ------- Income from operations 92,236 107,953 Interest expense 56,551 45,124 Loss on rights for convertible notes 4,549 - Refinancing and extinguishment of debt and interest rate derivatives 17,461 - Gain on sale of subsidiary stock (1,292) - Other income, net (60) (297) --- ---- Income before income tax expense 15,027 63,126 Income tax provision 3,463 24,013 ----- ------ Net income $11,564 $39,113 ======= ======= Earnings per common share---Basic $0.13 $0.43 ===== ===== Earnings per common share---Diluted $0.09 $0.42 ===== ===== Weighted average number of common shares outstanding: Basic 91,836 91,044 Diluted 153,602 94,066 SEALY CORPORATION CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) (Unaudited) Nine Months Ended ----------------- August 30, August 31, 2009 2008 ---- ---- Operating activities: Net income $11,564 $39,113 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Depreciation and amortization 23,840 25,763 Deferred income taxes (7,303) 1,847 Impairment charges 1,326 873 Amortization of deferred gain on sale-leaseback (485) - Paid in kind interest on convertible notes 1,820 - Amortization of discount on new senior secured notes 351 - Amortization of debt issuance costs and other 2,925 1,761 Loss on rights for convertible notes 4,549 - Share-based compensation 7,381 2,550 Excess tax benefits from share-based payment arrangements - (781) Loss on sale of assets 383 348 Write-off of debt issuance costs related to debt extinguishments 2,113 - Loss on termination of interest rate swaps 15,232 - Payment to terminate interest rate swaps (15,232) - Gain on sale of subsidiary stock (1,292) - Other, net (2,458) 1,083 Changes in operating assets and liabilities: Accounts receivable (27,628) (16,538) Inventories 5,684 715 Prepaid expenses and other current assets 14,080 2,549 Other assets (1,434) 3,049 Accounts payable 5,195 25,731 Accrued expenses 6,752 (26,824) Other liabilities (7,150) 3,539 ------ ----- Net cash provided by operating activities 40,213 64,778 ------ ------ Investing activities: Purchase of property, plant and equipment (8,669) (21,102) Proceeds from sale of property, plant and equipment 10,385 34 Net proceeds from sale of subsidiary 1,237 - Investments in and loans to unconsolidated affiliate (2,322) - ------ --- Net cash provided by (used in) investing activities 631 (21,068) --- ------- Financing activities: Cash dividends - (6,811) Proceeds from issuance of long-term obligations 3,343 8,114 Repayments of long-term obligations (15,668) (23,821) Repayment of old senior term loans (377,181) - Proceeds from issuance of new senior secured notes 335,916 - Proceeds from issuance of related party notes 177,132 - Repayment of related party notes (83,284) - Proceeds from issuance of convertible notes, net 83,284 - Borrowings under revolving credit facilities 140,904 277,658 Repayments under revolving credit facilities (205,304) (281,085) Exercise of employee stock options, including related excess tax benefits (330) 824 Debt issuance costs (27,421) - Net cash provided by (used in) financing activities 31,391 (25,121) ------ ------- Effect of exchange rate changes on cash 1,009 (2,497) ----- ------ Change in cash and equivalents 73,244 16,092 Cash and equivalents: Beginning of period 26,596 14,607 ------- ------- End of period $99,840 - $30,699 ======= ======= RECONCILIATION OF ADJUSTED EBITDA TO OPERATING INCOME AND ADJUSTED EBITDA MARGIN TO OPERATING MARGIN NON GAAP MEASURES Three Months Ended: ------------------------------------------------ August 30, August 31, 2009 2008 --------------------- ---------------------- (percentage (percentage (in of net (in of net thousands) sales) thousands) sales) Income from operations $39,183 11.2% $32,221 8.0% Depreciation and amortization 8,102 2.3% 8,643 2.1% Adjustments for debt covenants: Non-cash compensation 5,164 1.5% 555 0.1% KKR consulting fees 655 0.2% 546 0.1% Severance charges 229 0.1% 66 0.0% Restructuring related costs - 0.0% 2,189 0.5% Product line discontinuance - 0.0% 1,356 0.3% Other (a) 334 0.1% 1,212 0.3% --- ----- Adjusted EBITDA $53,667 15.4% $46,788 11.6% ======= ======= Nine Months Ended: ------------------------------------------------ August 30, August 31, 2009 2008 ------------------------ ---------------------- (percentage (percentage (in of net (in of net thousands) sales) thousands) sales) Income from operations $92,236 9.6% $107,953 9.2% Depreciation and amortization 23,840 2.5% 25,763 2.2% Adjustments for debt covenants: Non-cash compensation 7,387 0.8% 2,530 0.2% KKR consulting fees 2,196 0.2% 546 0.0% Severance charges 2,171 0.2% 3,271 0.3% Restructuring related costs - 0.0% 2,894 0.2% Product line discontinuance - 0.0% 1,356 0.1% Other (a) 2,951 0.3% 3,495 0.3% ----- ----- Adjusted EBITDA $130,781 13.7% $147,808 12.6% ======== ======== (a) Consists of various immaterial adjustments Sealy Corporation Fully Diluted Share Count Reconciliation (in thousands) Three Months Nine Months ------------ ----------- Fully Diluted Shares 8/31/08 93,538 94,066 Change in basic shares 615 792 Convertible Notes 177,088 60,549 Reduction in stock options (269) (1,756) Reduction in restricted shares (148) (154) Restricted share unit grants 8,172 - Other 160 105 --- --- Fully Diluted Shares 8/30/09 279,156 153,602

Sealy Corporation

CONTACT: Mark D. Boehmer, VP & Treasurer of Sealy Corporation,
+1-336-862-8705

Web Site: http://www.sealy.com/

SPAC Sponsored by Greenhill Announces Closing of Iridium Acquisition and Stock Offering

NEW YORK, Sept. 29 /PRNewswire-FirstCall/ -- Greenhill & Co., Inc. ("Greenhill") today announced that GHL Acquisition Corp. ("GHL Acquisition"), the special purpose acquisition company sponsored by Greenhill, has completed its acquisition of Iridium Holdings and a simultaneous offering of 16,000,000 newly issued shares of its common stock. The combined company has been renamed Iridium Communications Inc. . Following the planned conversion of its convertible note, Greenhill will own 8,874,887 shares of Iridium common stock and warrants to purchase 4,000,000 shares of Iridium common stock with an exercise price of $11.50 per share. Scott L. Bok, Co-Chief Executive Officer of Greenhill, and Robert H. Niehaus, Chairman of Greenhill Capital Partners, will be members of the Board of Directors of Iridium.

"We are very pleased with the results of the offering and the support from the stockholders of GHL Acquisition for the transaction. Iridium now has a strong group of shareholders who are excited by its business model and opportunities for continued growth. We look forward to working with the Board of Directors and management of Iridium as it embarks on the next stage of its life as a public company," commented Scott L. Bok, Co-Chief Executive Officer of Greenhill.

Forward-Looking Statements and Other Disclosure

This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. The words "anticipates," "may," "can," "believes," "expects," "projects," "intends," "likely," "will," "to be" and other expressions that are predictions of or indicate future events, trends or prospects identify forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Greenhill or GHL Acquisition to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to, uncertainties regarding the timing of the proposed transaction with Iridium, whether the transaction will be approved by GHL Acquisition's stockholders, whether the closing conditions will be satisfied (including receipt of regulatory approvals), as well as industry and economic conditions, and competitive, legal, governmental and technological factors. There is no assurance that Greenhill or GHL Acquisition's expectations will be realized. If one or more of these risks or uncertainties materialize, or if Greenhill or GHL Acquisition's underlying assumptions prove incorrect, actual results may vary materially from those expected, estimated or projected. The forward-looking statements speak only as of the date of this press release or as of the date they are made, and, except as required by law, Greenhill undertakes no obligation to update forward-looking statements.

This press release is for informational purposes only and does not constitute an offer of any securities for sale.

Contact: Richard J. Lieb, Chief Financial Officer Greenhill & Co., Inc. (212) 389-1800

Greenhill & Co., Inc.

CONTACT: Richard J. Lieb, Chief Financial Officer of Greenhill & Co.,
Inc., +1-212-389-1800

Allscripts Reports Fiscal 2010 First Quarter ResultsGAAP EPS of 9 Cents and Non-GAAP EPS of 15 cents

CHICAGO, Sept. 29 /PRNewswire-FirstCall/ -- Allscripts-Misys Healthcare Solutions, Inc. (Allscripts or the Company) today announced its financial results for the three months ended August 31, 2009, its first quarter of fiscal 2010.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO)

Total revenue for the three months ended August 31, 2009 was $164.9 million, compared to $92.8 million for the same period last year. Non-GAAP revenue for the three months ended August 31, 2009 was $167.5 million, compared to non-GAAP revenue of $164.7 million for the same period last year. Non-GAAP revenue for the three months ended August 31, 2009 and 2008 are comprised of revenue from Allscripts and Misys Healthcare (Misys), respectively, for the full three-month period of each respective year, giving effect to the add-back of a deferred revenue adjustment of $2.6 million recorded for GAAP purposes in the three month period ended August 31, 2009. In addition, non-GAAP revenue for three months ended August 31, 2008 excludes $9.9 million in prepackaged medications revenue that were recorded for GAAP purposes. Allscripts disposed of its prepackaged medications business on March 16, 2009. Please see "Explanation of Non-GAAP Financial Measures" below for a discussion of non-GAAP measures.

Gross margin percentage was 54.0% for the first quarter of fiscal 2010, compared to 53.9% for the same period last year. Based on non-GAAP revenue for each respective quarter, gross margin percentage was 54.7% for the first quarter of fiscal 2010, compared to 53.9% during the first quarter of fiscal 2009.

Net income for the three months ended August 31, 2009 was $12.9 million compared to net income of $5.4 million for the same period last year. Earnings for the three months ended August 31, 2009 were $0.09 cents per diluted share.

Non-GAAP net income for the three months ended August 31, 2009 was $22.2 million, compared to non-GAAP net income of $14.8 million for the same period last year, representing an increase of 50.0%. Non-GAAP net income for the three months ended August 31, 2009 and 2008 are comprised of net income from Allscripts and Misys, respectively, for the full three-month period of each respective year, giving effect to the add-back of acquisition-related amortization of $3.5 million and $2.4 million, respectively, net of tax; total stock-based compensation expense of $2.0 million and $1.5 million, respectively, net of tax; and transaction-related expenses of $2.4 million and $4.2 million, net of tax. Non-GAAP net income for the three months ended August 31, 2009 also gives effect to a deferred revenue adjustment of $1.5 million, net of tax; and the three months ended August 31, 2008 eliminates prepackaged medications net income of $0.5 million. Non-GAAP earnings for the three months ended August 31, 2009 were $0.15 cents per diluted share.

As of August 31, 2009 the Company had cash and marketable securities of $86.9 million.

"Allscripts posted solid results this quarter across all of our key metrics," said Glen Tullman, Chief Executive Officer of Allscripts. "Our results are a reflection of a successful merger, a focused effort on the processes critical to our growth, and great execution by our team. We're seeing strong demand for our products, even in advance of the federal stimulus incentives that we expect will accelerate adoption as we work towards our vision of transforming healthcare into a connected system of health."

Conference Call

Allscripts will conduct a conference call today, September 29, 2009 at 4:30 PM Eastern Daylight Time to discuss the Company's earnings and other information. The conference call can be accessed via the Internet at http://www.allscripts.com/, or by dialing (877) 230-5050 and requesting the Allscripts earnings call. International callers can access the audio portion of the webcast by dialing (973) 532-4923 and requesting the Allscripts Investor Presentation. A Microsoft Windows Media Player web replay will be available four hours after the conclusion of the call for a period of two weeks at http://www.allscripts.com/ or by calling (800) 642-1687 - or (706) 645-9291 for international callers - ID # 27582277.

(Minimum requirements to listen to the call online are: Microsoft Windows Media Player software, downloadable free from http://windowsmedia.com/download/download.asp, an Internet connection, and speakers or earphones).

Basis of Presentation

The Company's results for the three months ended August 31, 2009 include results of Allscripts for the complete fiscal quarter. The Company's GAAP results for the three months ended August 31, 2008 include only the results of Misys. A subsidiary of Allscripts merged with Misys, formerly a division of Misys plc, on October 10, 2008, at which time the legal name of Allscripts became Allscripts-Misys Healthcare Solutions, Inc.

Explanation of Non-GAAP Financial Measures

Allscripts reports its financial results in accordance with generally accepted accounting principles, or GAAP. To supplement this information, Allscripts presents in this press release non-GAAP revenue and net income, including non-GAAP net income on a per share basis, which are non-GAAP financial measures under Section 101 of Regulation G under the Securities Exchange Act of 1934, as amended. Non-GAAP revenue consists of GAAP revenue and legacy Allscripts revenue for periods prior to the consummation date of the Misys merger and adds back the deferred revenue adjustment booked for GAAP purposes and excludes revenue from prepackaged medications. Non-GAAP net income consists of GAAP net income and includes legacy Allscripts net income for periods prior to the consummation date of the Misys merger, excludes acquisition-related amortization, stock-based compensation expense under SFAS No. 123R, and transaction-related expenses, adds back the deferred revenue adjustment and excludes net income from prepackaged medications, in each case net of any related tax benefit.

-- Acquisition-Related Amortization. Acquisition-related amortization expense is a non-cash expense arising from the acquisition of intangible assets in connection with acquisitions or investments. Allscripts excludes acquisition-related amortization expense from non-GAAP net income because it believes (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of Allscripts business operations and (ii) such expenses can vary significantly between periods as a result of new acquisitions and full amortization of previously acquired intangible assets. Investors should note that the use of these intangible assets contributed to revenue in the periods presented and will contribute to future revenue generation and should also note that such expense will recur in future periods. -- Stock-Based Compensation Expense. Stock-based compensation expense is a non-cash expense arising from the grant of stock awards to employees. Allscripts excludes stock-based compensation expense from non-GAAP net income because it believes (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of Allscripts business operations and (ii) such expenses can vary significantly between periods as a result of the timing of grants of new stock-based awards, including grants in connection with acquisitions. Investors should note that stock-based compensation is a key incentive offered to employees whose efforts contributed to the operating results in the periods presented and are expected to contribute to operating results in future periods and should also note that such expense will recur in future periods. -- Transaction-Related Expenses. Transaction-related expenses are fees and expenses, including legal, investment banking and accounting fees, incurred in connection with announced transactions. Allscripts excludes transaction-related expenses from non-GAAP net income because it believes (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of Allscripts business operations and (ii) such expenses can vary significantly between periods. -- Deferred Revenue Adjustment. Deferred revenue adjustment reflects the fair value adjustment to deferred revenues acquired in connection with the transactions consummated with Misys plc on October 10, 2008. The fair value of deferred revenue represents an amount equivalent to the estimated cost plus an appropriate profit margin, to perform services related to legacy Allscripts software and product support, which assumes a legal obligation to do so, based on the deferred revenue balances as of October 10, 2008. Allscripts adds back this deferred revenue adjustment for non-GAAP revenue and non-GAAP net income because it believes the inclusion of this amount directly correlates to the underlying performance of Allscripts operations. -- Prepackaged Medications. As noted, Allscripts disposed of the prepackaged medications business on March 16, 2009. The results of this business have been excluded from non-GAAP revenue and net income because Allscripts believes this provides the most relevant comparison of the underlying performance of Allscripts operations.

Management also believes that non-GAAP revenue and net income provide useful supplemental information to management and investors regarding the underlying performance of the Company's business operations and facilitates comparisons to our historical operating results. Management also uses this information internally for forecasting and budgeting as it believes that the measure is indicative of the Company's core operating results. Note, however, that non-GAAP revenue and net income are performance measures only, and they do not provide any measure of the Company's cash flow or liquidity. Non-GAAP financial measures are not in accordance with, or an alternative for, measures of financial performance prepared in accordance with GAAP and may be different from non-GAAP measures used by other companies. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with Allscripts' results of operations as determined in accordance with GAAP. Investors and potential investors are encouraged to review the reconciliation of non-GAAP financial measures with GAAP financial measures contained within the attached condensed consolidated financial statements.

About Allscripts

Allscripts uses innovation technology to bring health to healthcare. More than 160,000 physicians, 800 hospitals and nearly 8,000 post-acute and homecare organizations utilize Allscripts to improve the health of their patients and their bottom line. The Company's award-winning solutions include electronic health records, electronic prescribing, revenue cycle management, practice management, document management, hospital care management, emergency department information systems and homecare automation. Allscripts is the brand name of Allscripts-Misys Healthcare Solutions, Inc. To learn more, visit http://www.allscripts.com/.

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future are forward-looking statements within the meaning of these laws. These forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; competitive pressures including product offerings, pricing and promotional activities; our ability to establish and maintain strategic relationships; undetected errors or similar problems in our software products; compliance with existing laws, regulations and industry initiatives and future changes in laws or regulations in the healthcare industry; possible regulation of the Company's software by the U.S. Food and Drug Administration; the possibility of product-related liabilities; our ability to attract and retain qualified personnel; our ability to identify and complete acquisitions, manage our growth and integrate acquisitions; the ability to recognize the benefits of the merger with Misys Healthcare Systems, LLC ("Misys"); the integration of Misys with the Company and the possible disruption of current plans and operations as a result thereof; the implementation and speed of acceptance of the electronic record provisions of the American Recovery and Reinvestment Act of 2009; maintaining our intellectual property rights and litigation involving intellectual property rights; risks related to third-party suppliers; our ability to obtain, use or successfully integrate third-party licensed technology; breach of our security by third parties; and the risk factors detailed from time to time in our reports filed with the Securities and Exchange Commission, including our 2009 Annual Report on Form 10-K available through the Web site maintained by the Securities and Exchange Commission at http://www.sec.gov/. The Company undertakes no obligation to update publicly any forward-looking statement, whether as a result of new information, future events or otherwise.

Allscripts-Misys Healthcare Solutions, Inc. Condensed Consolidated Balance Sheets (In millions) August 31, May 31, 2009 2009 ---- ---- (Unaudited) ASSETS Current assets: Cash and cash equivalents $84.8 $71.2 Accounts receivable, net 150.3 155.1 Deferred taxes, net 1.5 1.1 Inventories 2.3 2.6 Prepaid expenses and other current assets 36.5 31.1 ---- ---- Total current assets 275.4 261.1 Long-term marketable securities 2.1 2.3 Fixed assets, net 17.5 17.3 Software development costs, net 16.4 13.5 Intangible assets, net 222.4 227.8 Goodwill 417.9 418.4 Other assets 12.5 12.4 ---- ---- Total assets $964.2 $952.8 ====== ====== LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable $18.9 $19.3 Accrued expenses 41.3 41.5 Accrued compensation and benefits 10.3 16.6 Deferred revenue 86.6 86.0 Other current liabilities 1.2 0.8 --- --- Total current liabilities 158.3 164.2 Long-term debt 40.0 63.7 Deferred taxes, net 24.1 20.4 Other liabilities 4.2 4.1 --- --- Total liabilities 226.6 252.4 Total stockholders' equity 737.6 700.4 ----- ----- Total liabilities and stockholders' equity $964.2 $952.8 ====== ====== Allscripts-Misys Healthcare Solutions, Inc. Condensed Consolidated Statements of Operations (In millions, except per-share amounts) (Unaudited) Three Months Ended August 31, ----------- 2009 2008 ---- ---- Revenue: System sales $33.5 $13.0 Professional services 15.9 7.4 Maintenance 59.4 36.7 Transaction processing and other 56.1 35.7 ---- ---- Total revenue 164.9 92.8 ----- ---- Cost of revenue: (a) System sales 19.6 7.2 Professional services 15.5 6.5 Maintenance 20.9 15.1 Transaction processing and other 19.8 14.0 ---- ---- Total cost of revenue 75.8 42.8 ---- ---- Gross profit 89.1 50.0 Selling, general and administrative expenses (b) 52.9 32.8 Research and development 12.0 8.0 Amortization of intangible assets 2.6 0.2 --- --- Income from operations 21.6 9.0 Interest expense (0.7) (0.1) Interest income and other, net 0.1 - --- --- Income before income taxes 21.0 8.9 Provision for income taxes (8.1) (3.5) ---- ---- Net income $12.9 $5.4 ===== ==== Net income per share-basic and diluted $0.09 $0.06 ===== ===== Weighted-average shares of common stock outstanding used in computing basic net income per share 143.0 82.9 ===== ==== Weighted-average shares of common stock outstanding used in computing diluted net income per share 148.0 82.9 ===== ==== (a) Includes amortization of intangibles of $3.1 and $0.4 in the three months ended August 31, 2009 and 2008, respectively. (b) Includes stock-based compensation of $3.3 and $0.8 in the three months ended August 31, 2009 and 2008, respectively. Allscripts-Misys Healthcare Solutions, Inc. Condensed Non-GAAP Financial Information (In millions, except per-share amounts) (Unaudited) Three Months Non-GAAP Revenue Ended August 31, ----------- 2009 2008 ---- ---- Total revenue, as reported $164.9 $92.8 AHS revenue pre-merger (a) - 81.8 Deferred revenue adjustment 2.6 - Elimination of prepackaged medications - (9.9) ------ ------ Total Non-GAAP Revenue $167.5 $164.7 ====== ====== Three Months Non-GAAP Net Income (All adjustments tax effected at 39%) Ended August 31, ----------- 2009 2008 ---- ---- Net income, as reported $12.9 $5.4 AHS net income pre-merger (a) - 1.8 Elimination of prepackaged medications - (0.5) Deferred revenue adjustment 1.5 - Stock-based compensation expense 2.0 1.5 Acquisition-related amortization expense 3.5 2.4 Transaction-related expense 2.4 4.2 Tax adjustment for the fiscal year 2010 period to 39% (0.1) - ----- ----- Non-GAAP Net Income $22.2 $14.8 ===== ===== Weighted average shares of common stock outstanding used in computing diluted non-GAAP adjusted net income per share 148.0 82.9 ----- ----- Non-GAAP Net Income Per Share - diluted $0.15 $0.18 ===== ===== (a) AHS revenue and net income, pre merger, from continuing operations. Physicians Interactive was excluded as a discontinued operation in historical periods and was divested in September 2008.

Photo: http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com Allscripts-Misys Healthcare Solutions, Inc.

CONTACT: Investors, Seth Frank, Vice President, Investor Relations,
+1-312-506-1213, seth.frank@allscripts.com, or Media, Todd Stein, Senior
Manager/Public Relations, +1-312-506-1216, todd.stein@allscripts.com, or Dan
Michelson, Chief Marketing Officer, +1-312-506-1217,
dan.michelson@allscripts.com, all of Allscripts

Web Site: http://www.allscripts.com/

Consolidation in AME's Mobile Market Will Continue for Next Several Years, Finds Pyramid

CAMBRIDGE, Mass., Sept. 29 /PRNewswire/ -- In-country consolidation in the mobile market has already begun in Africa and the Middle East and will become a more important trend over the next few years, pushing incumbents to find new ways to protect their customer base, according to a new report from Pyramid Research (http://www.pyr.com/), the telecom research arm of the Light Reading Communications Network (http://www.lightreading.com/).

Three Is Company, Four Is a Crowd: Mobile Players Proliferate in AME examines the factors that we expect will drive consolidation over the coming years. We start by recapping the dynamics behind the increasing numbers of licenses and operators. The 17-page report then examines the degree of success of third, fourth, and fifth entrants in terms of subscription market share. A look at some of the successful strategies which incumbent operators are adopting to protect their customer base follows. Finally we examine the first case of in-country consolidation - and its likely implications for African mobile operators. Download an excerpt of this report here: http://www.pyramidresearch.com/downloads.htm?id=5&sc=PR092909_INAME1.7

Competition in mobile markets across Africa and the Middle East will intensify as new licenses continue to be made available in Africa, even though many late entrants struggle to establish a sustainable business where three or more networks are already in operation, notes Dearbhla McHenry, analyst at Pyramid Research and author of the report. "Although third entrants in Africa and the Middle East have gained as much as 37 percent of their markets within three years, the picture for fourth and fifth operators is gloomier: our analysis suggests that market shares of 8.7 percent and 4.7 percent, respectively, are more realistic targets," she adds.

"Several factors determine whether a late entrant to a mobile market in Africa and the Middle East will overcome the odds and gain significant market share, as explained in this report," says McHenry. "It is often the case that operators entering a market where another operator has recently launched will tend to find it difficult to establish an additional brand," she explains. The region's leading operators, however, are getting better at reducing churn and increasing loyalty. "International and regional operators, in particular, have an advantage in being able to implement best practices learned overseas - MTN, for instance, has experienced growing competition in many of its markets, has maintained a strong position, for instance in Cote d'Ivoire, Ghana, and Nigeria," says McHenry.

At the end of July 2009, one of the first in-country mergers in the region took place in Sierra Leone. Market leader Africell agreed to buy Millicom-owned operator Tigo for an undisclosed sum. "We believe that this event may signal the start of a new trend, since several other operators look similarly vulnerable to acquisition," says McHenry. "As a result, we believe in-country consolidation, as well as operators exiting markets, will be an increasingly common event over the coming five years," she adds.

Three Is Company, Four Is a Crowd: Mobile Players Proliferate in AME is part of Pyramid Research's Africa and the Middle East Telecom Insider report series. This report is priced at $595 and can be purchased online here: http://www.pyramidresearch.com/store/ins_ame_090925.htm?sc=PR092909_INAME1.7 or by contacting Amalia Vega via email at avega@pyr.com.

For more information about Pyramid Research's products and services, please visit http://www.pyr.com/ or contact us at info@pyr.com.

About Pyramid Research

Pyramid Research (http://www.pyr.com/) offers practical solutions to the complex demands our clients face in the telecommunications, media and technology industries. Our analysis is uniquely positioned at the intersection of emerging markets, emerging technologies and emerging business models, powered by the bottom-up methodology of our market forecasts for over 100 countries - a distinction that has remained unmatched for more than 25 years. As the telecom research arm of the Light Reading Communications Network, Pyramid Research works with Heavy Reading, providing the communications industry's most comprehensive market data, trusted research and insightful technology analysis.

About Light Reading

Founded in 2000, Light Reading (http://www.lightreading.com/) is the leading online media, research, and focused event company serving the $3 trillion worldwide communications market. Lightreading.com is the ultimate source for technology and financial analysis of the communications industry, leading the media sector in terms of traffic, content, and reputation. Light Reading's research arms, Heavy Reading and Pyramid Research, provide the most comprehensive communications research, market data, and technology analysis in close to 100 markets around the world. Light Reading produces nearly 20 targeted communications events including TelcoTV, Ethernet Expo New York and Ethernet Expo London, The Tower Summit @ CTIA, and Optical Expo, as well as focused one-day events tailored for cable, mobile, and wireline executives. Light Reading was acquired by United Business Media in August 2005 and operates as a unit of TechWeb.

About TechWeb

TechWeb (http://techweb.com/aboutus), the global leader in business technology media, is an innovative business focused on serving the needs of technology decision-makers and marketers worldwide. TechWeb produces the most respected and consumed media brands in the business technology market. Today, more than 13.3 million* business technology professionals actively engage in our communities created around our global face-to-face events, Interop, Web 2.0, Black Hat, and VoiceCon; online resources such as the TechWeb Network, Light Reading, Intelligent Enterprise, InformationWeek.com, bMighty.com, and The Financial Technology Network; and the market leading, award-winning InformationWeek, TechNet Magazine, MSDN Magazine, and Wall Street & Technology magazines. TechWeb also provides end-to-end services including next-generation performance marketing, integrated media, research, and analyst services. TechWeb is a division of United Business Media, a global provider of news distribution and specialist information services with a market capitalization of more than $2.5 billion.

*13.3 million business decision-makers: based on number of monthly connections

About United Business Media Limited

UBM (UBM.L) focuses on two principal activities: worldwide information distribution, targeting and monitoring; and, the development and monetization of B2B communities and markets. UBM's businesses inform markets and serve professional commercial communities - from doctors to game developers, from journalists to jewelry traders, from farmers to pharmacists - with integrated events, online, print, and business information products. Our 6,500 staff in more than 30 countries are organized into specialist teams that serve these communities, bringing buyers and sellers together, helping them to do business and their markets to work effectively and efficiently. For more information, go to http://www.unitedbusinessmedia.com/.

Press contact: Jennifer Baker +1 617 871-1910 jbaker@pyr.com

Pyramid Research

CONTACT: Jennifer Baker, Pyramid Research, +1-617-871-1910,
jbaker@pyr.com

Web Site: http://www.pyr.com/

SouthernLINC Wireless Adds Motorola Debut(TM) i856 to Product PortfolioFirst iDEN slider phone has multimedia capabilities

ATLANTA, Sept. 29 /PRNewswire/ -- SouthernLINC Wireless, a Southern Company , today announced the availability of the Motorola Debut(TM) i856. The Debut i856 is the first Motorola Integrated Digital Enhanced Network (iDEN) device that combines the power of Push To Talk two-way radio with a slider-style design.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090507/CL13145LOGO ) (Photo: http://www.newscom.com/cgi-bin/prnh/20090929/CL83154 )

Packed with style and features, including a dedicated music player button, expandable memory - up to 8 gigabytes with a microSD card - and 3.5 millimeter audio jack, the Debut will be a favorite of music aficionados.

The Debut also offers: -- Push To Talk two-way radio (PTT) with a menu of PTT Features that allows messages, pictures, events, My Info contents, contact and location information to be sent via the PTT button. Data access is required for some features. -- A large, 176 X 220, 2.2-inch color display. -- An integrated 1.3 megapixel digital camera for still photos and video capture. -- GPS and Bluetooth® included. -- LINCaround and Java capabilities. -- Enhanced text messaging capabilities, including auto cleanup, URL support, threading, word completion and next word prediction. -- Vibracall, speakerphone and voice activated dialing.

"The Debut i856 brings a new form factor to our phone portfolio," said Rodney Johnson, vice president of sales and distribution for SouthernLINC Wireless. "The phone's slide open design is appealing because it protects the keypad in a purse or pocket. The external music player controls enable this phone to serve as an ideal MP3 player as well."

The Motorola Debut i856 is now available through SouthernLINC Wireless sales representatives, sales and service locations, authorized dealers or online at http://www.southernlinc.com/phones.asp. In-stock availability may vary by location.

About SouthernLINC Wireless

SouthernLINC Wireless, a Southern Company , is an Atlanta-based regional wireless carrier with network coverage in the major metro and rural areas of Alabama, Georgia, southeast Mississippi and northwest Florida. SouthernLINC Wireless bundles multiple communication options, including Push To Talk two-way radio, cellular service, text messaging, wireless Internet access and wireless data, into one hand-held device. For more information, please call 1-800-818-LINC (5462) or visit http://www.southernlinc.com/.

About Southern Company

With 4.4 million customers and more than 42,000 megawatts of generating capacity, Atlanta-based Southern Company is the premier energy company serving the Southeast. A leading U.S. producer of electricity, Southern Company owns electric utilities in four states and a growing competitive generation company, as well as fiber optics and wireless communications. Southern Company brands are known for excellent customer service, high reliability and retail electric prices that are below the national average. Southern Company is consistently listed among the top U.S. electric service providers in customer satisfaction by the American Customer Satisfaction Index. Visit our Web site at http://www.southerncompany.com/.

Photo: http://www.newscom.com/cgi-bin/prnh/20090507/CL13145LOGO
http://www.newscom.com/cgi-bin/prnh/20090929/CL83154
AP PhotoExpress Network: PRN6 SouthernLINC Wireless

CONTACT: Jamie Schaff, SouthernLINC Wireless, +1-678-443-1527,
jschaff@southernco.com; or Lindsey Ford, Edelman, +1-404-262-3000,
Lindsey.Ford@edelman.com

Web Site: http://www.southernlinc.com/

Finalistes de la 11e édition annuelle des Platts Global Energy Awards

NEW YORK, September 29 /PRNewswire/ --

En annonçant aujourd'hui les finalistes de l'édition 2009 de ses Platts Global Energy Awards (Prix mondiaux de l'énergie), Platts met en relief le fait que le secteur mondial de l'énergie évolue de plus en plus vers des solutions à la fois de long terme et respectueuses de l'environnement, puisqu'elle annonce un nombre record de candidats et de finalistes dans les catégories des technologies durables, de l'efficacité énergétique et des initiatives vertes.

<< Il est non seulement encourageant de voir autant d'organisations se placer en tête de la durabilité de l'approvisionnement à travers des innovations respectueuses de l'écologie, mais il est également impressionnant de constater que le nombre total de prix décernés a atteint des niveaux record malgré le contexte économique mondial très difficile >>, a affirmé Larry Neal, président de Platts. << Le fait d'arriver en finale dans le présent environnement économique constitue un véritable exploit. Nous félicitons chacun de nos finalistes et avons hâte d'annoncer les lauréats début décembre. >>

Établi en 1999, le programme d'octroi de prix Platts Global Energy Awards est devenu le plus renommé dans l'industrie et il récompense l'innovation, le leadership et les meilleures performances dans des catégories couvrant l'ensemble du secteur énergétique. Parmi les catégories nouvelles ou mises à jour pour 2009 figurent : Initiative énergétique verte de l'année, Programme d'efficacité énergétique de l'année, Contrat de l'année, Projet d'infrastructure de l'année et Producteur énergétique de l'année.

Les finalistes des 17 catégories de performances ont été sélectionnés parmi une liste de plus de 200 nominés, sur la base des critères correspondant à chaque catégorie, en tenant compte du profil de la société et de ses résultats financiers sur la période de temps définie. La Société énergétique de l'année sera choisie parmi l'ensemble des finalistes par un jury indépendant composé d'anciens membres d'organismes nationaux de contrôle, d'anciens dirigeants de grandes sociétés énergétiques, d'universitaires de renom et d'experts internationaux dans le domaine de l'énergie.

Les lauréats de l'édition 2009 des Platts Global Energy Awards seront annoncés lors d'un dîner de gala de remise des prix, jeudi 3 décembre, au Cipriani Wall Street de New York, qui devrait rassembler plus de 500 cadres supérieurs du secteur de l'énergie du monde entier. Capgemini participe à nouveau en tant que parrain principal pour la septième année consécutive et sera secondé par Elster Integrated Solutions et SolArc.

Il est nécessaire de s'inscrire à l'avance afin de prendre part au 11e dîner annuel de remise des prix. Les membres de la presse accréditée pourront participer en tant qu'invités à condition de s'être préalablement inscrits. Les caméras de télévision sont bienvenues. Pour de plus amples informations concernant l'événement ou le parrainage, veuillez contacter Vicki Peterson au 970-461-1090 ou à l'adresse Vicki_peterson@platts.com ou vous rendre sur www.globalenergyawards.com.

Les finalistes des différentes catégories sont les suivants : PDG de l'année Greg Boyce, Peabody Energy Antonio Brufau, Repsol Peter Duprey, ACCIONA Energy North America Chengyu Fu, CNOOC Limited James Hackett, Anadarko Petroleum Company Lewis Hay, FPL Group, Inc. Ralph Izzo, Public Service Enterprise Group (PSEG) John C.S. Lau, Husky Energy, Inc. Milton B. Lee, CPS Energy Wayne Leonard, Entergy Corporation Aubrey McClendon, Chesapeake Energy Corporation Vincent de Rivaz, EDF Energy Technologie commerciale de l'année Alter NRG Badger Licensing L.L.C. CNOOC Limited EnerNOC, Inc. InStep Software Lennox Industries Inc. Process Dynamics Inc. Repsol Shell Global Solutions Space-Time Insight Programme de développement communautaire de l'année AES Dominicana Chesapeake Energy Corporation CPS Energy El Paso Corporation Entergy Corporation (assistance pour les personnes à faible revenu) Entergy Corporation (financement universitaire) Northeast Utilities PTT Public Limited Company Qalhat LNG Reliance Industries Ltd. Reliance Infrastructure Ltd. Valero Energy Corporation Contrat de l'année Arch Coal, Inc. Belwind NV Chesapeake Energy Corporation Enel SpA Gas Natural Mansfield Oil Company MOL Nyrt. NRG Energy, Inc. Peabody Energy T-Power NV Valero Energy Corporation Secteur d'aval de l'année Jamshoro Joint Venture Limited (JJVL) Mansfield Oil Company Petrobras S.A. S-OIL Corporation Sovcomflot (SCF) Group Programme en faveur de l'efficacité énergétique de l'année Ameren Illinois Utilities Exel Logistics Exelon Corporation IKEA North America Johnson & Johnson Michaels Stores, Inc. MidAmerican Energy Holdings Company Orion Energy Systems Inc. Pacific Gas and Electric Company Reliance Industries Ltd. Staples Corporation Stream Energy Producteur énergétique de l'année Anadarko Petroleum Corporation CNOOC Limited Coal India Limited Peabody Energy Petrobras S.A. Projet d'ingénierie énergétique de l'année Entergy Corporation (transfert automatique de charge) Entergy Corporation (University of Arkansas) Mirant Corporation MyCelx Technologies Shell Global Solutions YANSAB (Yanbu National Petrochemical Co) Projet de construction de l'année dans le domaine de l'énergie et des ressources naturelles (ENR) Advatech LLC Black & Veatch City Water, Light & Power (CWLP), FPL Group, Inc. Navy CFAY Pepco Energy Services, Inc. SGT LLC Shell Global Solutions SNC-Lavalin Constructors Inc. Tetra Tech Inc. URS Washington Division (Palo Seco) URS Washington Division (Prairie Creek) Initiative d'énergie verte de l'année Alpine Energy Group LLC Elementa Group Inc. FPL Group, Inc. Iberdrola, S.A. Indian Oil Corporation Ltd. Naval Facilities Engineering Command PG&E Corporation Public Service Enterprise Group (PSEG) Recurrent Energy (North Face) Recurrent Energy (San Francisco) SolarCity Zorlu Enerji Prix du leadership industriel Arch Coal, Inc. Black & Veatch Corporation California ISO Carbon Capture and Storage Association Chesapeake Energy Corporation Duke Energy Energy Curtailment Specialists, Inc (ECS) Entergy Corporation MidAmerican Energy Holdings Company Petrobras S.A. PJM Interconnection Southern California Edison Projet d'infrastructure de l'année ATP Oil & Gas Corporation BP Australia Bronzeoak Ltd. Entergy Corporation San Diego Gas and Electric Company (SDG&E) Tetra Tech, Inc. Prix récompensant l'ensemble d'une carrière Jean-Pierre Benque, EDF International North America Christopher Bloch, Boyle Energy Services and Technology Tom Casten, Recycled Energy Development (RED) Roger Duncan, Austin Energy Sheila Hollis, Duane Morris LLP Bill Klesse, Valero Energy Corporation Hardev Singh Kohli, Reliance Industries Ltd. Lee Raymond, Exxon Mobil Corporation, retraité Larry Weyers, Integrys Energy Group Campagne marketing de l'année Alliant Energy Indian Oil Corporation Ltd. Peabody Energy PTT Public Limited Company Southern California Edison Toronto Hydro Corporation Société énergétique de l'année Consolidated Edison, Inc. CPS Energy Entergy Corporation Public Service Enterprise Group (PSEG) Reliance Infrastructure Ltd. Prix de l'étoile montante CoaLogix EcoTek Lighting Enzen Global Solutions Private Limited Jamshoro Joint Venture Limited (JJVL) LanzaTech Stream Energy Innovation technologique durable de l'année Abengoa Solar eSolar, Inc. HDR, Inc. Ice Energy InEnTec LLC Public Service Enterprise Group (PSEG) RSI Silicon Shell Global Solutions Sopogy, Inc. Tessera Solar Total TURBINA IPD Ltd. Wade Adams Group

Retrouvez des informations clés sur Platts Global Energy Awards et une liste des lauréats des années précédentes ainsi que des photos sur le site Internet.

Avant la cérémonie de remise des Platts Global Energy Awards, les finalistes, des économistes et d'autres participants se rassembleront pour un débat animé sur la viabilité de solutions énergétiques durables à l'occasion du forum des perspectives énergétiques Platts Global Energy Outlook Forum le 2 décembre dans la ville de New York. Lors du forum, sur le thème de << The Outlook for Sustainability: Charting a Course Amidst Economic, Geopolitical and Environmental Challenges >> (Perspectives pour la durabilité : déterminer un plan d'action dans un contexte de défis économiques, géopolitiques et environnementaux), un discours d'ouverture sera prononcé par Steven Koonin, sous-secrétaire des sciences au ministère américain de l'Énergie (U.S. Department of Energy), et deux tables rondes seront organisées. La presse ainsi que les autres participants doivent s'inscrire à l'avance pour prendre part au Global Energy Outlook Forum.

À propos de Platts : Platts, division de The McGraw-Hill Companies (NYSE: MHP), est un leader mondial en matière de prestation d'informations sur l'énergie et les marchandises. Ayant à son actif près d'un siècle d'expérience en affaires, Platts est au service de clients répartis dans plus de 150 pays à partir de 17 bureaux situés partout dans le monde. Platts exerce ses activités sur les marchés du pétrole, du gaz naturel, de l'électricité, des émissions, de l'énergie nucléaire, du charbon, des produits pétrochimiques et des métaux. Les services d'information, de tarification, d'analyse et de conférence en temps réel de Platts permettent aux marchés de fonctionner de façon efficace et transparente. Les négociateurs, les gestionnaires des risques, les analystes, et les leaders de l'industrie dépendent de Platts pour les aider à prendre de meilleures décisions en matière de négociation et d'investissement. Pour de plus amples renseignements, veuillez consulter le http://www.platts.com.

Contacts médias hors Etats-Unis : En Asie : Casey Yew +65-653-06552. En Europe : Shiona Ramage +44-207-1766153.

Contact : Kathleen Tanzy +1-212-904-2860 kathleen_tanzy@platts.com

Platts

Kathleen Tanzy, +1-212-904-2860, kathleen_tanzy@platts.com

United Airlines Releases 2008-2009 Corporate Responsibility Report - Every Action Counts(SM)

CHICAGO, Sept. 29 /PRNewswire-FirstCall/ -- United Airlines today released its 2008-2009 Corporate Responsibility Report - Every Action Counts(SM), highlighting the company's actions and commitments to business discipline and leadership, safety, customer satisfaction, employee development and opportunity, community engagement, and environmental stewardship.

Every Action Counts(SM) underscores United's progress toward making a meaningful difference in the cities and communities where its people live, work, travel, and do business. It illustrates the company's efforts to achieve industry leadership in safety and customer satisfaction; its ongoing support to our communities to address important economic and social needs; and the progress in implementing responsible environmental initiatives that reduce impact in the air and on the ground.

"Corporate responsibility means forging strong relationships with the people and communities we serve and using our resources to make a difference," said Glenn Tilton, chairman, president, and chief executive officer of United Airlines. "Our success is driven by how we work as a team to improve our airline and better serve our customers--how we are stepping up to meet environmental challenges and addressing community needs, and how we work together to make every action count."

Highlights within the report include: Communities and Local Engagement

United uses its resources - aircraft, people, and global network - to aid organizations that help others. United cares about the economic issues that affect its communities and works collaboratively to help them prosper.

-- United enables and promotes customer donations to causes and partners that are important through the company's Charity Miles program, resulting in more than $1 billion worth of miles since 1996. -- United contributes to and enables the support of nearly $12 million to its community partners and causes in 2008. -- United employees and customers are committed to battling cancer; United employees have raised $2 million for the Breast Cancer Network of Strength through annual participation in the Walk to Empower, and United's customers donated more than 100 million Mileage Plus miles and enabled the company to deliver 20,000 teddy bears to children with cancer. -- United provides inner-city youth opportunities to build their skills and reach their potential; United mentors high school students, sponsors youth learning programs such as After School Matters and Junior Achievement, and connects students with enriching experiences such as the opportunity to participate in the inauguration of President Barack Obama. -- United participates on the boards of nearly 40 civic and non-profit organizations, providing expertise and ideas to benefit the communities it serves. The Environment

United is working across the company and industry to minimize carbon dioxide emissions, conserve energy resources, and explore energy alternatives and expand waste management efforts.

-- United saves 1 billion pounds of fuel through conservation initiatives from 2004 through 2008. -- United improves fuel efficiency by 32% between 1990 and 2008 (gallons per revenue ton mile). -- United has nearly 1,800 alternative-fueled and zero-emitting vehicles, representing nearly 25% of the active Ground Support Equipment (GSE) fleet. -- United will save 3 million gallons of jet fuel per year by using EcoPower Engine Wash. The Business

United reinforced its commitment to safety and strengthening its business discipline by improving service, launching award-winning products, and reducing costs.

-- United maintains a focus on safety that is at the core of its business and the foundation of everything it does. -- United is number one among its competitors in on-time performance year to date, awarding frontline employees more than $18 million for meeting on-time performance goals. -- United invested more than $4.3 billion in Total Rewards for its people in 2008 and promotes programs and unique training experiences to develop its employees and cultivate future leaders. -- United is the first U.S. carrier to provide award-winning 180 degree lie-flat seats in both international first and business class, and Travel Options that enable customers to enjoy an enhanced travel experience.

To access the Corporate Responsibility Report--Every Action Counts(SM) online, please visit united.com/corporateresponsibility or contact us directly at crinfo@united.com.

About United

United Airlines operates approximately 3,300* flights a day on United and United Express to more than 200 U.S. domestic and international destinations from its hubs in Los Angeles, San Francisco, Denver, Chicago and Washington, D.C. With key global air rights in the Asia-Pacific region, Europe and Latin America, United is one of the largest international carriers based in the United States. United also is a founding member of Star Alliance, which provides connections for our customers to 916 destinations in 160 countries worldwide. United's 48,000 employees reside in every U.S. state and in many countries around the world. News releases and other information about United can be found at the company's Web site at united.com.

*Based on United's forward-looking flight schedule for July 2009 to June 2010

*Includes Scheduled and Charter Operations

United Airlines

CONTACT: Worldwide Press Office of United Airlines, +1-312-997-8640

Web Site: http://www.united.com/

Micromem Technologies Inc. Interim Filings

TORONTO, Sept. 29 /PRNewswire-FirstCall/ -- Micromem Technologies Inc. (the "Company") (CNSX: MRM, OTCBB: MMTIF) announces it has filed its interim financial statements for the period ended July 31, 2009, together with the Management's Discussion & Analysis on SEDAR and EDGAR. These documents may be viewed at http://www.sedar.com/ and by searching EDGAR at http://www.sec.gov/.

About Micromem and MASTInc

MASTInc is a wholly owned U.S.-based subsidiary of Micromem Technologies Inc., a publicly traded (OTC BB: MMTIF, CNSX: MRM) company. MASTInc responsibly analyzes the specific industry sectors to create intelligent game-changing applications that address unmet market needs. By leveraging its expertise and experience with sophisticated magnetic sensor applications, MASTInc successfully powers the development and implementation of innovative solutions for healthcare/biomedical, natural resource exploration, government, information technology, manufacturing, and other industries. Visit http://www.micromeminc.com/ http://www.mastinc.com/.

Safe Harbor Statement

This press release contains forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions and uncertainties that could cause the Company's actual results to differ materially from those projected in such forward-looking statements. In particular, factors that could cause actual results to differ materially from those in forward looking statements include: our inability to obtain additional financing on acceptable terms; risk that our products and services will not gain widespread market acceptance; continued consumer adoption of digital technology; inability to compete with others who provide comparable products; the failure of our technology; the infringement of our technology with proprietary rights of third parties; inability to respond to consumer and technological demands; inability to replace significant customers; seasonal nature of our business; and other risks detailed in our filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the date made and are not guarantees of future performance. We undertake no obligation to publicly update or revise any forward-looking statements. When used in this document, the words "believe," "expect," "anticipate," "estimate," "project," "plan," "should," "intend," "may," "will," "would," "potential," and similar expressions may be used to identify forward-looking statements.

The CNSX or any other securities regulatory authority has not reviewed and does not accept responsibility for the adequacy or accuracy of this press release that has been prepared by management. Listing: NASD OTC-Bulletin Board - Symbol: MMTIF CNSX - Symbol: MRM Shares issued: 89,383,003 SEC File No: 0-26005

Micromem Technologies Inc.

CONTACT: Jason Baun, 1-877-388-8930

GoIp Global (GOIG) Establishes Long-Term Advertisement Partnership with Bell Canada

TORONTO, Sept. 29 /PRNewswire-FirstCall/ -- GoIP Global, Inc. (Pink Sheets:GOIG - News) (http://www.goipglobal.com/) is pleased to announce the following news from its Canadian based operating subsidiaries EEGlobal and 401bz Inc.

EE global, a media company, and 401bz Inc. specializing Chinese media, technology and marketing in North America, has established a long-term advertisement partnership with Bell Canada, the biggest telecom carrier in Canada http://www.bell.ca/. Based on the partnership, 401bz Inc uses its two Chinese newspapers, and its other extensive networks as platforms to help Bell Canada to penetrate into Canadian Chinese communities. This Chinese community consists of approximately 1.3 million populations in Canada, and is the biggest visible minority groups in Canada.

This agreement is with EE global, a media company, and 401bz Inc and forms part of the GOIG asset base with the recently announced merger. GOIG has completed a filing on Pink Sheets under "supplemental Info" of the Bell's weekly advertisements of the two weekly Chinese newspaper of 401bz. See Pink Sheets link

http://www.pinksheets.com/pink/quote/quote.jsp?symbol=GOIG

In other company news the company will soon be launching its new corporate web site under a new domain http://www.goigcorp.com/ The following is a temporary preview link for goigcorp.com http://67.220.209.2/~goigcorp/

To be included in GOIG's e-mail database for press releases and industry updates, please subscribe at or opt in with your email address at this link http://www.minamargroup.com/updates/

More updates will follow shortly, from GOIG' recently announced merger companies based in Canada and China.

Safe Harbor Statement

Information in this news release may contain statements about future expectations, plans, prospects or performance of GoIP Global, Inc. that constitute forward-looking statements for purposes of the safe harbor Provisions under the Private Securities Litigation Reform Act of 1995. The words or phrases "can be," "expects," "may affect," "believed," "estimate," "project," and similar words and phrases are intended to identify such forward-looking statements. GoIP Global, Inc. cautions you that any forward-looking information provided by or on behalf of GoIP Global, Inc. is not a guarantee of future performance. None of the information in this press release constitutes or is intended as an offer to sell securities or investment advice of any kind. GoIP Global, Inc.'s actual results may differ materially from those anticipated in such forward-looking statements as a result of various important factors, some of which are beyond GoIP Global, Inc.'s control. In addition to those discussed in GoIP Global, Inc.'s press releases, public filings, and statements by GoIP Global, Inc.'s management, including, but not limited to, GoIP Global, Inc.'s estimate of the sufficiency of its existing capital resources, GoIP Global, Inc.'s ability to raise additional capital to fund future operations, GoIP Global, Inc.'s ability to repay its existing indebtedness, the uncertainties involved in estimating market opportunities and, in identifying contracts which match GoIP Global, Inc.'s capability to be awarded contracts. All such forward-looking statements are current only as of the date on which such statements were made. GoIP Global, Inc. does not undertake any obligation to publicly update any forward-looking statement to reflect events or circumstances after the date on which any such statement is made or to reflect the occurrence of unanticipated events.

CONTACT: Investor Relations Department, (302) 357-9915 (IR), http://www.minamargroup.com/helpdesk; 1st Level Support Retail Clients General Inquiry, 1-800-365-4331 (M&A), Corporate Matters, http://www.minamargroup.com/ (M&A), http://www.minamargroup.net/ (IR)

GoIP Global, Inc.

CONTACT: Investor Relations Department, (302) 357-9915 (IR),
http://www.minamargroup.com/helpdesk; 1st Level Support Retail Clients General
Inquiry, 1-800-365-4331 (M&A), Corporate Matters, http://www.minamargroup.com/ (M&A),
http://www.minamargroup.net/ (IR)

Western Coal to grow production to 10 million tonnes

VANCOUVER, Sept. 29 /PRNewswire-FirstCall/ -- Western Coal Corp (TSX: WTN, WTN.WT and WTN.DB and AIM: WTN) ("Western" or "Company"), announced today at its Annual and Special Meeting ("Meeting") of shareholders that it is planning to expand production to 10 million tonnes of coal per year by 2013.

John Byrne, Chairman of Western Coal said at the Meeting, "The opportunities and returns are tremendous. The projects include:

- Expanding Brule to 2 million tonnes per year, - Developing an underground mine at Perry Creek which will expand the operations at Wolverine to nearly 3 million tonnes, - Re-starting and expanding Willow Creek to a 1.8 million tonne producer of PCI and hard coking coal, - Purchasing new equipment at the two mines, Maple Coal and Gauley Eagle, in West Virginia to their full potential of 1.8 million tonnes (or 2 million tons) and 1.4 million tonnes (or 1.5 million tons), respectively, and - Assisting Energybuild Group Plc, which we have a 50.6% interest, to grow to 750,000 tonnes per year, with further opportunities beyond that."

The Company expects to initiate the development of both Brule and Willow Creek in the first half of calendar 2010. This allows Western to take advantage of the recovery in world metallurgical coal markets, with spot prices for coking coal now over US$170 per tonne. Assuming the continued recovery in steel demand, the Company expects next year contract coal prices to be significantly higher.

John Hogg, President & CEO of Western Coal states, "With current operations performing better than expected along with the expectation of higher coal prices in the near-term, we believe the time is right to expand our operations. Cash costs at Wolverine are now around $100 per tonne, which is almost 50% lower than fiscal 2009 costs. The year-to-date effective stripping ratio at Wolverine is now approximately 13 to 1, which is almost 20% lower than the average in fiscal 2009 of 16 to 1, and trending towards life-of-mine ratio of 10 to 1."

All resolutions at the Meeting were approved by shareholders, including the name change of the Company to Western Coal Corp.

About Western

Western is a producer of high quality metallurgical and thermal coal from mines located in northeast British Columbia (Canada) and West Virginia (USA). The mines have the capacity to produce 7 million tonnes per year and have over 20 years of coal reserves. Western also owns a 50.6% interest Energybuild (EBG: AIM) which produces high quality anthracite and thermal coals in South Wales (UK). Other interests owned include a 45% interest in Xtract Energy (XTR: AIM), 20% interest in NEMI Northern Energy & Mining (NNE.A: TSX) and 100% of a small gold and antimony operation in Australia. The Company is headquartered in Vancouver, BC, Canada, and trades on the AIM and TSX stock exchanges under the symbol "WTN". More information can be found at http://www.westerncoal.com/

Reference materials: - 2009 AGM Chairman's remarks: http://www.westerncoal.com/_pdf/presentations/Chair_2009_AGM_speech.pdf - 2009 AGM President's presentation: http://www.westerncoal.com/_pdf/presentations/2009_AGM_presentation.pdf

Western Canadian Coal Corp.

CONTACT: David Jan, Director, Investor Relations, (604) 608-2692,
David.Jan@westerncoal.com

Avista Celebrates Noxon Rapids 50th Anniversary, Clark Fork Settlement Agreement 10th AnniversaryCelebration planned for Thursday, Oct. 1 in Noxon, Montana

SPOKANE, Wash., Sept. 29 /PRNewswire-FirstCall/ -- Avista will celebrate both the 50th anniversary of the first power generated at its Noxon Rapids hydroelectric dam and the first 10 years of successful implementation of the Clark Fork Settlement Agreement Thursday, Oct. 1 in Noxon, Mont.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040128/SFW031LOGO)

Noxon Rapids is part of Avista's Clark Fork Hydroelectric Project on the lower reach of the Clark Fork River, which also includes the Cabinet Gorge dam 22 miles downstream in Idaho. The two dams generate nearly 80 percent of Avista's hydroelectric power, and account for almost half of Avista's total generation capability.

Avista was formed as Washington Water Power in 1889 with the construction of the Monroe Street Dam on the Spokane River. Washington Water Power (later renamed Avista) began construction of the Noxon Rapids Dam in 1956, after completing Cabinet Gorge in 1953. The construction of Noxon Rapids was a boon to Sanders County and the surrounding area, nearly doubling the population of the county and infusing millions of dollars into the local economy. Noxon Rapids began generating power on July 7, 1959, with a dedication ceremony in 1960 drawing a crowd of thousands to the community of Noxon.

The Clark Fork Settlement Agreement, a multi-stakeholder agreement for managing and protecting the natural resources associated with the hydro project, was signed in 1999 after several years of collaboration. The following year, in an unprecedented action, the Federal Energy Regulatory Commission (FERC) issued a new single license for the project, built around the agreement, a year prior to the expiration of the existing Cabinet Gorge license. This single license to operate both Cabinet Gorge and Noxon Rapids took effect March 1, 2001. The collaborative agreement ensures local participation in the protection of natural resources affected by the dam over the life of the 45-year license.

"Our Clark Fork project has provided clean, renewable power to residents of the Northwest for more than half a century," Avista Utilities President Dennis Vermillion said. "But more than that - it has given us 50 years of working with others to protect the environment and 50 years of being good neighbors and giving back to the communities we live and work in."

Avista and its community partners have been marking these milestones throughout the year with a variety of activities, including a poster contest for local students. These activities will culminate with an anniversary celebration in Noxon, Thursday, Oct. 1. A rededication ceremony will begin at 1 p.m. at the lower Noxon Rapids overlook, and will include remarks by Scott Morris, chairman, president and chief executive officer of Avista Corp., Richard Opper, director of the Montana Department of Environmental Quality, and a representative of Montana Trout Unlimited. The community celebration will be held at Pilgrim Creek Park beginning at 3 p.m., and will include public tours of Noxon Rapids Dam, as well as a picnic, music, displays and poster contest awards. All times are Mountain Time.

Read the story of Noxon Rapids here. Oct. 1 Schedule of events and tour information: 1 p.m. MDT Rededication ceremony at lower Noxon Rapids overlook (Those interested in attending the re-dedication ceremony should meet at Pilgrim Creek Park at noon, as parking will not be available at the overlook.) -- Remarks by Scott Morris, chairman, president and chief executive officer, Avista Corp. -- Remarks by Richard Opper, director, Montana Department of Environmental Quality -- Remarks by Montana Trout Unlimited representative 3 p.m. Community picnic begins at Pilgrim Creek Park -- Food and beverages available -- Bull Trout Trailer, Avista Sun Car -- Music by The Marauders 4 p.m. Wattson, Avista's Energy Watchdog, children's events First public tours of Noxon Rapids -- Adults must register and show photo ID to take tour. -- Children under 18 must be accompanied by adult. -- Buses will provide transportation from Pilgrim Creek Park and back, approximately 90-minute total time. -- Noxon Rapids is not a public facility and therefore is not ADA accessible. Tour participants must be able to walk for an extended amount of time and climb stairs. 4:30 p.m. Remarks by Dennis Vermillion, president, Avista Utilities Poster contest awards 5:30 p.m. Second public tours of Noxon Rapids (see above)

Avista Corp. is an energy company involved in the production, transmission and distribution of energy as well as other energy-related businesses. Avista Utilities is our operating division that provides electric service to 353,000 homes and businesses and natural gas to 313,000 homes and businesses in three Western states, serving more than 492,000 customers. Avista's primary, non-regulated subsidiary is Advantage IQ. Our stock is traded under the ticker symbol "AVA." For more information about Avista, please visit http://www.avistacorp.com/.

This news release contains forward-looking statements regarding the company's current expectations. Forward-looking statements are all statements other than historical facts. Such statements speak only as of the date of the news release and are subject to a variety of risks and uncertainties, many of which are beyond the company's control, which could cause actual results to differ materially from the expectations. These risks and uncertainties include, in addition to those discussed herein, all of the factors discussed in the company's Annual Report on Form 10-K for the year ended Dec. 31, 2008, and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2009.

Photo: http://www.newscom.com/cgi-bin/prnh/20040128/SFW031LOGO
http://photoarchive.ap.org/
PRN Photo Desk photodesk@prnewswire.com Avista Corp.

CONTACT: Anna Scarlett of Avista Corp., +1-509-495-4916,
anna.scarlett@avistacorp.com, or Avista 24/7 Media Access, +1-509-495-4174

Web Site: http://www.avistacorp.com/

ReBuilder Medical Technologies, Inc. Reports LOI With National DME Distributor.

CHARLES TOWN, W.Va., Sept. 29 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) announced today that they have penned a letter of intent with a major national Durable Medical Equipment company to introduce the ReBuilder for neuropathy and arthritis to DMEs throughout the country.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO)

"We expect to have a signed agreement in place within the next week," says David B. Phillips, Ph.D., the CEO of RBRM.

Additionally, Dr. Phillips reports: "We already have DMEs calling us because of the tremendous demand created by the acceptance of our neuropathy and arthritis products from patients who have already gone to their doctors and secured a prescription."

John Romanic, one of the principals of the national distributor added, "We are in a unique position to promote the ReBuilder to DMEs because of the wonderful success we have had with the ReBuilder with patients who suffer from neuropathy or arthritis pain. We expect to introduce and sign up to 100 suppliers to the ReBuilder this year."

With the acceptance of Medicare, sales have increased dramatically for RBRM. Diabetic patients develop neuropathy as a complication to their diabetes, and arthritis is increasing with the graying of America.

Inquiries can be made at http://www.rebuildermedical.com/.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.

Photo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, photodesk@prnewswire.com ReBuilder Medical Technologies, Inc.

CONTACT: CONTACT: David B. Phillips, CEO, ReBuilder Medical
Technologies, Inc., +1-540-454-2664, davidphillipsmail@yahoo.com

Axion Power(TM) Amends Securities Investment by the Quercus Trust; Adds Three New Members to Board of DirectorsNames David Gelbaum, David Anthony and Joseph Bartlett to Board

NEW CASTLE, Penn., Sept. 29 /PRNewswire-FirstCall/ -- Axion Power International, Inc. (BULLETIN BOARD: AXPW) , a leading developer of advanced lead-carbon PbC® batteries, today announced that it has amended its financing agreement with The Quercus Trust and expanded its Board of Directors to 11 members. Each of the new board members, David Gelbaum, David Anthony and Joseph Bartlett, was elected to a three-year term and is affiliated with The Quercus Trust.

The Quercus Trust, which originally made a staged $18 million investment in Axion Power, has agreed to invest an additional $2 million in connection with the Company's anticipated $10 million minimum capital raise. In addition, the new agreement waives any previously accrued liquidated damages in the early agreement and calls for the exercise for warrants previously issued to Quercus by Axion to be reset from $2.60 per share to $0.75 per share.

Axion Power CEO, Thomas Granville said: "We continue to strengthen our relationship with The Quercus Trust and welcome the new board members. Each of these very distinguished new members brings significant expertise to our board. We believe the addition of this group is a concrete endorsement of the future potential of our company."

Mr. Gelbaum, 60, is a noted private investor in environmental oriented funds and trustee of The Quercus Trust Fund (well known for regularly supporting clean technology and "green earth" initiatives). For 17 years he worked as a securities analyst at Oakley Sutton.

Mr. Anthony, 48, an experienced entrepreneur, venture capitalist and educator, is managing director of New York based 21 Ventures. Mr. Anthony has held the managing director position with this venture capital firm since 2003. He also serves on the boards of Agent Video Intelligence, 3GSolar, BioPetroClean, Juice Wireless, Open Energy and VOIP Logic. Prior to 21 Ventures, Anthony launched Notorious Entertainment, a developer of multimedia brands. He has a bachelor's degree in Economics from George Washington University and an MBA from The Tuck School of Business at Dartmouth College.

Mr. Bartlett, 51, is counsel to The Quercus Trust, serves on the boards of directors of a number of clean technology companies and has practiced corporate and securities law since 1985. From September 2004 until August 2008 he was a partner at Greenberg Glusker LLP in Los Angeles. From September 2000 until September 2004 he was a partner at Spolin Silverman Cohen and Bartlett.

"Our ability to draw on David Gelbaum's highly successful, 36-year career in the finance and investment banking industry will be a tremendous asset to us as we move forward and sort through the numerous market opportunities that are available to us." Granville added. "David's Quercus Trust has been a leading investor in the clean energy and technology space, making his decision to join the board especially significant. David Anthony is also totally attuned to the cleantech and clean energy space and has lengthy experience serving on boards of young companies like ours. Joseph Bartlett is counsel to David Anthony's Quercus Trust fund and an experienced attorney who has been very successful throughout his own career. We look forward to the benefit of his experience."

About Axion Power International Inc

Axion has developed and patented a next generation energy storage device that won the prestigious Frost & Sullivan Technology Award for North America in the field of lead-acid batteries. According to Frost & Sullivan, Axion's new PbC batteries have "the potential to revitalize the lead-acid battery industry by breathing new life into an established technology that is not well suited to the requirements of important new applications like hybrid electric vehicles and renewable power."

Axion Power International Inc is the industry leader in the field of lead-acid-carbon energy storage technologies. Axion believes this new battery technology is the only class of advanced battery that can be assembled on existing lead-acid battery production lines throughout the world without significant changes to production equipment and fabrication processes. It also believes it will be able to manufacture carbon electrode assemblies in volume at low cost using standard automated production methods that are commonly used in other industries. If and when its electrode manufacturing methods are fully developed, Axion believes it will be able to sell carbon electrode assemblies as virtual plug-and-play replacements for lead-based negative electrodes used by all other lead-acid battery manufacturers. Axion's future goal, after filling their plant's lead-carbon battery production, is to become the leading supplier of carbon electrode assemblies for the lead-acid battery industry.

For more information, visit http://www.axionpower.com/. Contacts Axion Power International Inc. Thomas Granville, CEO (724) 654 9300 Allen & Caron Inc Rudy Barrio (Investors) r.barrio@allencaron.com (212) 691-8087 Brian Kennedy (Media) brian@allencaron.com (212) 691-8087

Axion Power International, Inc.

CONTACT: Thomas Granville, CEO of Axion Power International Inc.,
+1-724-654 9300, or Investors, Rudy Barrio, r.barrio@allencaron.com, or Media,
Brian Kennedy, brian@allencaron.com, both of Allen & Caron Inc,
+1-212-691-8087, for Axion Power International Inc.

Web Site: http://www.axionpower.com/

Spare Backup to be Bundled in Popular Anti-Virus Software at Major U.K. Electronics Retail Chain

PALM DESERT, Calif., Sept. 29 /PRNewswire-FirstCall/ -- Spare Backup, Inc. (BULLETIN BOARD: SPBU) today announced that it has entered into a memorandum of understanding ("MOU") to have its data backup and cloud computing services bundled in a popular anti-virus software package offered by a major U.K electronics retailer throughout its chain of stores.

The MOU, referenced in an 8K filing by Spare Backup, Inc. ("Spare Backup") on September 24, 2009, provides for the terms under which Spare Backup will receive a payment for each anti-virus product sold by the U.K. retailer containing the Spare Backup bundle. All parties will operate under the MOU until such time as a definitive agreement is reached which is anticipated to be completed within 45 days of September 23, 2009.

"We are excited to be working with two exceptional partners in combination to unveil this all encompassing product. Together we are providing a solution to anti-virus and remote backup, combined in one offering. This additional distribution channel shall help add customers to our already growing customer base, eventually enabling our subscribers to reach out to all of our other offerings, including our newly launched consumer 'cloud.' It truly is the best of all worlds and we are committed to moving forward with this partnership," stated Cery Perle, CEO of Spare Backup.

For additional information, visit http://www.sparebackup.com/. For investor relations, please contact our investor relations department at 760-779-0251 Ext. 224 or ir@sparebackup.com.

About Spare Backup, Inc.:

Spare Backup, Inc. specializes in helping consumers, small office/home office users and small to mid-sized businesses protect their computer data quickly, automatically and cost-effectively. The company's flagship Spare Backup product is the first totally automated online backup service that intelligently selects, secures and stores files without any user intervention, automatically backing up documents, email, music, photos and other PC files on a continuous basis or according to the schedule of the user's choice. The company is headquartered in Palm Desert, California.

Safe Harbor Statement:

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking information made on the company's behalf. All statements, other than statements of historical facts, which address the company's expectations of sources of capital or which express the company's expectation for the future with respect to financial performance or operating strategies can be identified as forward-looking statements. Such statements made by the company are based on knowledge of the environment in which it operates, but because of the possibility of unknown factors, as well as other factors beyond the control of the company, actual results may differ materially from the expectations expressed in the forward-looking statement. An investment in our common stock involves a significant degree of risk. You should not invest in our common stock unless you can afford to lose your entire investment. You should consider carefully all risk factors and other information in our annual report and quarterly filings before deciding to invest in our common stock. If any of the following risks and uncertainties develops into actual events, our business, financial condition or results of operations could be materially adversely affected and you could lose your entire investment in our company.

Spare Backup, Inc.

CONTACT: Spare Backup, Inc., investor relations, +1-760-779-0251, ext.
224, ir@sparebackup.com

Web Site: http://www.sparebackup.com/

Hostopia Launches New Email and Webmail Platform

SHOREVIEW, Minn., Sept. 29 /PRNewswire-FirstCall/ -- Hostopia, a business unit of Deluxe Corporation , announced today that it has upgraded its 3 million email users to its latest version of Webmail 5 as well as a new, enhanced version of its EasyMail(TM) administrator control panel.

Today, Hostopia is the exclusive provider of email services to customers of more than 330 service providers, including global telecoms, cable operators, ISPs and hosting companies. Each of these providers and their millions of end-users, are either using, or have immediate access to the new version.

"This email system development exemplifies the benefits of a true, cloud-based SaaS system," said Paul D. Engels, Hostopia's chief marketing officer. "Rather than planning through months of expensive and disruptive software and hardware updates, we simply develop, test and propagate updates to the cloud. Our users wake up the next morning to an all-new and improved feature experience - without paying a cent in project or new licensing fees."

Hostopia's new Webmail 5 with EasyMail(TM) features: -- Ajax-based system that allows full drag-and-drop of email items -- Calendar events for an intuitive desktop feel -- Interface that mirrors desktop applications while being entirely web-based -- "Infinite scroll" feature allows instantaneous review of large inboxes -- Increased standard storage -- Capability to launch collaboration features such as calendar sharing and SyncSuite which allows users to synchronize contact lists, calendars and tasks between their desktop, internet and mobility devices -- Help messages and guided wizards via graphics and animation -- Auto-detect and set up user mail preferences About Deluxe Corporation

Deluxe Corporation is a growth engine for small businesses and financial institutions. Through its industry-leading businesses and brands, the Company helps small businesses and financial institutions attract and retain customers. The Company employs a multi-channel strategy to provide a suite of lifecycle driven solutions to its customers. In addition to its personalized printed products, the Company offers a growing suite of business services, including logo design, payroll, web design and hosting, business networking and other web-based services to help small business grow. In the financial services industry, Deluxe sells check programs and fraud prevention, customer loyalty and retention programs to help banks build lasting relationships and grow core deposits. The Company also sells personalized checks, accessories, stored value gift cards and other services directly to consumers. For more information about Deluxe, visit http://www.deluxe.com/.

About Hostopia

Hostopia is a leading provider of web services that enable small- and medium-sized businesses to establish and maintain an Internet presence. The company's customers are communication services providers, including telecommunication carriers, cable companies, Internet service providers, domain registrars, and web hosting service providers. Hostopia's customers purchase their web services on a wholesale basis and resell these services under their own brands to small- and medium-sized businesses. The company provides customers with the technology, infrastructure, and support services to enable them to offer web services, while saving them research and development as well as capital and operating costs typically associated with the design, development, and delivery of web services. Nexthaus, Hostopia's wireless mobility technology unit, is a global leader in data and device synchronization and has developed industry-recognized SyncML solutions that feature wireless interoperability between PC's, handheld devices and mobile phones. For more information, visit http://www.hostopia.com/ and http://www.nexthaus.com/.

Deluxe Corporation

CONTACT: Jason Schumann of Beehive PR, +1-651-789-2237, for Deluxe
Corporation

Web Site: http://www.deluxe.com/
http://www.hostopia.com/

Cedar Shopping Centers' Director, Paul G. Kirk, Jr., Resigns to Accept Appointment to the U.S. Senate

PORT WASHINGTON, N.Y., Sept. 29 /PRNewswire-FirstCall/ -- Cedar Shopping Centers, Inc. today announced that Paul G. Kirk, Jr. has resigned as a director of the Company as the result of his appointment as a United States Senator for Massachusetts to the seat previously held by the late Senator Edward Kennedy. Senator Kirk, a director of the Company since 2005, also served as Lead Director and Chairman of the Company's Nominating and Corporate Governance Committee.

Leo S. Ullman, Cedar's CEO, stated, "Paul Kirk's (now Senator Kirk's) guidance and service as a director of our Company, and indeed, Lead Director, has been invaluable. His dedication to our Company and his service for five annual terms on our Board, has been enormously beneficial to Cedar and its stockholders. We will miss his sage advice, insights, judgment, thoughtfulness, elegance and humor. On behalf of our Board, our management team and all our colleagues, we know that he will serve the U.S. Senate, the Commonwealth of Massachusetts and the country with great distinction; we are extremely proud of our affiliation with Senator Kirk during the past five years; and we wish him every continued success and good fortune in his new position."

About Cedar Shopping Centers

Cedar Shopping Centers, Inc. is a fully-integrated real estate investment trust which focuses primarily on ownership, operation, development and redevelopment of "bread and butter" supermarket-anchored shopping centers in coastal mid-Atlantic and New England states. The Company presently owns and operates approximately 12.6 million square feet of GLA at 120 shopping center properties, of which approximately 75% are anchored by supermarkets and/or drugstores with average remaining lease terms of approximately 11 years. The Company's stabilized properties have an occupancy rate of approximately 95%. The Company has also announced a pipeline of approximately 11 substantially pre-leased primarily supermarket- and drugstore-anchored development properties.

Additional financial and descriptive information on the Company, its operations and its portfolio can be accessed through the Company's website at http://www.cedarshoppingcenters.com/.

Cedar Shopping Centers, Inc.

CONTACT: Cedar Shopping Centers, Inc., Leo S. Ullman, Chairman, CEO and
President, +1-516-944-4525, lsu@cedarshoppingcenters.com

Web Site: http://www.cedarshoppingcenters.com/

page 1     page 2     page 3     page 4     page 5     page 6     page 7     page 8     page 9     page 10     page 11     page 12    

News archive of December 2009
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31